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One of the principal ameliorating factors in β–thalassemias is the innate ability 
to produce HbF. Although the majority of adults shows traces of HbF, in rare 
cases, named Hereditary Persistence of Fetal Hemoglobin (HPFH), its value can 
reach levels of 15%–30%. 
cis–acting variants like deletions, point mutations and SNPs within the  
β–cluster can explain some of the variability; however 50% of the variance is 
unlinked to the β–cluster. 
In this study, healthy HPFH individuals were analyzed: Hb profile was defined 
by CE–HPLC, RP–HPLC, IEF and AUT–PAGE. Structural analysis of the γ 
genes promoters revealed 4 ndHPFH mutations, whose strength was studied by 
luciferase assays. 
A large deletion on the β–cluster (Sicilian δβ–thalassemia) was found in one 
sample by MLPA and GAP–PCR. 
One 
Aγ ndHPFH sample, also showing Gγ persistence, presented 2 new 
mutations on the 
Gγ promoter: luciferase assays demonstrated that the persistence 
of 
Gγ is not attributable to these mutations per se. 
Complete sequence of β genes showed β0(39) and β+(–87) β–thalassemia 
alleles; β+(–87) was found linked to a cis–acting polymorphic configuration 
associated with high HbF. 
Orkin haplotype analysis showed evidence of a unique association between  
Aγ –117 mutation and haplotype VII. 
The data presented in this thesis confirm the complexity of the globin switch 
and the heterogeneity of the molecular mechanisms underlying the persistence of 
HbF, emphasizing the importance of the molecular context of a mutation.
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1.1 Structure and function of Hemoglobin 
Hemoglobin, also spelled haemoglobin (Hb), is a heterotetrameric protein 
synthetized by red blood cells precursors. It is made up of four polypeptide chains, 
assembled in a quaternary structure in which two so called α–like chains (141 amino 
acid residues) associate with two β–like chains (146 amino acid). 
During development, eight human globin genes (Para. 1.2) express six different 
Hb types (Fig. 1): Hb Gower I (ζ2ε2), Gower II (α2ε2), and Portland (ζ2γ2) are found 
in the embryo; fetal Hb (HbF; α2γ2) is 
present mainly in the fetus, but also in the 
embryo and adult, whereas HbA (α2β2) and 
HbA2 (α2δ2) are seen in adults (Chap. 2). 
Also, all Hbs undergo post–translational 
modification forming minor Hb such as 
HbF1 (acetylated form of HbF) or HbA1C  
(non–enzymatic glicated form of HbA) 
(Steinberg et al., 2009). 
Although the polypeptides have different sequences of amino acids, each 
protein chain arranges into a set of α–helix, folding up in a similar three–dimensional 
tertiary structure called “globin”, comparable to the folding motif used in other 
proteins such as myoglobin. This particular folding creates a pocket for the prosthetic 
group heme (Fe–protoporphyrin IX); a polypeptide chain combined with a heme is 
called monomer or subunit of Hb. Heme allows the Hb in erythrocytes to bind O2 
reversibly and transport it from the lungs to respiring tissues (Steinberg et al., 2009). 
The folding is made up of seven or eight α–helix, named A to H starting from 
the amino end, while non–helical segments are named by the contiguous helix (e.g. 
AB, BC, …); residues within each segment are numbered from the amino end with 
an Arabic number (e.g. A1, AB1, and so on) (Watson and Kendrew, 1961). 
Figure 1 
Basic organization of human globin gene 
clusters and composition of Hb produced. 
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Hb tetramer have two quaternary structures: the T or deoxy conformer that has 
low oxygen affinity and the R or oxy conformer that has high oxygen affinity. 
Further fine–tuning of Hb function comes from its allosteric behavior triggered by 
the binding of two small negative effector molecules: 2,3–BPG, and protons to 
specific sites on the T structure distant from the heme groups (Forget and Bunn, 
2013). 
The transport of O2 differs in embryonic, fetal, and adult stages of 
development: early embryos obtain O2 from the maternal interstitial fluid using 
embryonic Hbs; fetus obtains its O2 via the placenta using fetal ones, while adult 
uses its adult Hbs. 
O2 affinity of HbF is higher than adult ones’ due to its lower affinity for the 
allosteric effector 2,3–BPG; this allows HbF to take oxygen from maternal HbA in 
the placenta (Steinberg et al., 2009). 
 
1.2 Structure of globin genes and their cluster organization 
The genes encoding the different globin chains of Hb are members of an 
ancient gene family and they share a common structural organization. 
In humans, as in all vertebrate species, different α–like and β–like globin 
chains are synthetized at progressive stages of development: before precise 
knowledge of globin gene organization, it was clear that there must exist at least one 
gene for each of the different globin chain (ζ, α, ε, γ, β, δ). Further studies based on 
HbF heterogeneity and globin variants showed that α and γ genes are duplicated and 
structurally different: the two α genes encode the same protein, while γ genes are 
different only for one amino acid (136 Gly/Ala: 
Gγ and Aγ, respectively).  
 
The coding region of each globin gene is interrupted by two introns, also called 
intervening sequences (IVS1 and IVS2). In the β–like globin genes, the introns 
interrupt the coding sequence between codons 30 and 31 and between codons 104 
and 105; in the α–globin gene family, IVS1 interrupt the coding sequence between 
codons 31 and 32 and IVS2 between codons 99 and 100 (Fig. 2 A). 
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The IVS1 is shorter than the IVS2 in both α– and β–globin genes, but IVS2 of 
the human β–globin gene is much longer than that of the α–globin gene. 
Globin genes are transcribed into a pre–mRNA and IVSs are subsequently 
removed to produce the mature mRNA (splicing). This process requires different 
consensus sequences, which are almost universally found at the 5’ (donor) and 3’ 
(acceptor) splice sites of introns, and the consensus sequence surrounding the A 
(Adenosine) in the so called “branch of the introns”. The dinucleotides GT (donor) 
and AG (acceptor) of the intron are essential and required for proper globin gene 
splicing (Steinberg et al., 2009). 
The mature mRNA is made up of a 5’ untranslated region (UTR), which drives 






A) General structure of globin genes  
B) The pathway for maturation and expression of mRNA of the globin genes 
(Steinberg et al., 2009) 
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α–like and β–like genes map on different chromosomes: the so called  
“β–globin cluster” maps on chromosome 11 (11p15.5), while “α–globin cluster” on 
chromosome 16 (16p13.3), 150 kb from the telomere of its short arm. 
 
 A.  B. 
 
In each cluster the active genes are arranged in the same order as they are 
expressed during the development (expressed genes are indicated in bold):  
 
• α–cluster (AC #: NG_000006). It spans about 30 kb and includes 4 functional 
genes and 3 pseudogenes. The order of genes is: 5’– ζ2 (HBZ, embryonic) – ψζ1 
(HBZP1 or HBZP) – μ or ψα2 (HBM or HBAP2) – ψα1 (HBAP1) – α2 (HBA2, fetal 
and adult) – α1 (HBA1, fetal and adult) – θ (HBQ1) – 3’ (Fig. 3 A). 
The α2 and α1 coding sequences are identical, however, the two genes differ 
slightly over the 5’–UTR and the introns, but significantly over the 3’–UTR. 
Although the protein products of the α2– and α1–genes are identical,  
α2–mRNA in reticulocytes, both in in fetal and adult life, predominates over  
α1–mRNA by approximately 3:1, probably as a result of differences at the level of 
transcription of the two genes. 
α2– and α1–mRNA have identical translational profiles and therefore should 
be produced with equal efficiencies, predicting a dominant role for the α2–globin 
locus. Two studies addressing this point come to different conclusions. In the first, it 
was found that α2 variants represented 24%–40% of total, whereas α1 variants 
Figure 3 
Organization of globin gene clusters. It is notable that the orientation with respect to the centromere 
(CEN) and telomere (TEL) are opposite. 
A) α–globin cluster 
B) β–globin cluster 
(Steinberg et al., 2009) 
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represented 11%–23%, suggesting a predominant role for the α2 gene at both mRNA 
and protein levels. The second study found that in heterozygotes the average 
proportion of stable variants resulting from α2 mutants (23.5%) was only slightly 
higher than from α1 mutations (19.7%), suggesting a less efficient translation of the 
α2–mRNA and a more equal contribution from the two genes at the protein level 
(Steinberg et al., 2009). 
The cluster shows three pseudo–globin genes: however in a recent work a 
transcript for a μ–globin was identified: it encodes for a 141 amino acid protein but 
generates non detectable μ–globin protein in human (Goh et al., 2005). Its closest 
relatives are the αD–globin genes actively expressed in red cells of reptiles and birds 
(Steinberg et al., 2009). It is interesting that μ–globin gene is not the only one 
lacking a detectable product: the θ–globin gene is also transcribed, but not translated 
at least at detectable levels (Hsu et al., 1988). Both genes are well conserved at the 
genomic level with appropriate splicing junctions and maintenance of open reading 
frames (ORFs). Like μ–globin, θ–globin has a highly regulated pattern of 
transcription in erythroid cells (Albitar et al., 1992). In addition, both genes 
demonstrate only fractional levels of transcription compared with the dominant α 
genes, and their deletion in humans seems to not affect the clinical phenotype (Fei et 
al., 1988). 
 
• β–cluster: (AC #: NG_000007 and AC #: U01317). It spans about 45 kb and 
includes 5 functional genes and 1 pseudogene. The order of genes is: 5’ – ε (HBE, 
embryonic) – Gγ (HBG2, fetal) – Aγ (HBG1, fetal) – ψβ1 (HBBP1) – δ (HBD, minor 
adult) – β (HBB, major adult) – 3’ (Fig. 3 B). 
HBG1 gene exist in two alleles coding for two globin that differ at codon 75: 
the mostly represented 
AγI (AC #: U01317, with Ile at codon 75) and the variant AγT 
(AC #: NG_000007, with Thr at cod. 75). The tetramer α2
AγT2 is called  
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The pseudogene ψβ1 is transcribed and spliced but the presence of mutations 
render it incapable of encoding a functional globin chain. 
These β–like genes have the same overall exonic structure, leading to the 
conclusion that they are derived from one ancestral gene. 
Note that the orientation with respect to the centromere (CEN) and telomere 
(TEL) are opposite: the α–like globin genes are transcribed toward CEN, whereas the 
β–like globin genes are transcribed toward TEL (Fig. 3 A and B) (Steinberg et al., 
2009). 
 
1.3 Genomic context of the α– and β–globin gene clusters 
The separation of α– and β–globin gene clusters to different chromosomes has 
allowed them to diverge into strikingly different genomic contexts, with 
consequential enigmatic understanding of their regulation. The β–globin gene cluster 
is A+T rich, with no CpG islands
1
 (Collins and Weissman, 1984), while the α–like 
globin gene cluster is highly G+C rich, with multiple CpG islands (Fischel–Ghodsian 
et al., 1987).  
This brings to important differences in the structure and regulation of the two 
gene clusters. The β–globin gene cluster is subject to tissue–specific DNA 
methylation, while, due to the presence of CpG islands, the α–globin gene cluster is 
not methylated in any cell type.  
β–like globin cluster have an increased accessibility of the chromatin only in 
expressing cells; in contrast, the α–like globin genes are in constitutively open 
chromatin (Steinberg et al., 2009). 
The types of genes that surround the α–like and β–like globin gene clusters are 
quite different (Fig. 4). 
                                                 
1
 The CpG islands are short regions (a few hundred base pairs) in which the CpG dinucleotides are not 
methylated; these have been associated with important functions such as promoters for transcription. 
Regions that are G+C rich tend to be enriched in genes expressed in an ample range of tissues; these 
genes also tend to have islands with an abundance of the dinucleotide CpG, in contrast to the rest of 
the genome, which has very few CpGs because these are the sites for DNA methylation when not 
organized in islands. 
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The β–like globin gene cluster is surrounded by olfactory receptor (OR) genes; 
OR gene cluster contain approximately 100 genes extending almost 1 million bp 
(Mb). Perhaps this has had an impact on natural selection for a powerful enhancer 
that could override the OR genes regulation in a chromosomal region devoted to 
olfactory–specific expression (Fig. 4 A).  
The α–like globin genes are surrounded by widely expressed genes (Fig. 4 B), 
such as MPG (DNA repair enzyme methyl purine glycosylase) and POLR3K 
(subunit of RNA polymerase III).  
 





Although the α–like globin gene cluster and surrounding DNA is in 
constitutively open chromatin, its histones are hyperacetylated (active chromatin) 
only in erythroid cells. 
Figure 4 
Genomic context of α– and β–cluster. 
 
A) β–globin gene cluster 
B) α–globin gene cluster 
(Steinberg et al., 2009) 
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It is possible that this region encompasses all the sequences needed in cis for 
appropriate regulation of the α–like globin genes: in fact the regions surrounding the 
α–like globin gene cluster have undergone inter– and intrachromosomal 
rearrangements in various vertebrate lineages, while the genes from POLR3K 
through HBQ1 (θ gene) have remained together in all species. 
Despite these many differences between the two clusters, the genes are 
expressed coordinately between the two loci, resulting in balanced production of  
α–like and β–like globins needed for the synthesis of Hbs, even though the 
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2. GLOBIN GENE SWITCHING 
Hb switching is characteristic of all animal species that use Hb for O2 
transport. Most species have the embryonic to adult globin switch, while humans and 
a few other mammals have two globin gene switches, from embryonic to fetal globin 
and from fetal to adult globin formation, occurring around the perinatal period  
(Fig. 5; see Para. 1.1 and 1.2).  
 
 
The switch from ε– to γ–globin production begins very early in gestation (HbF 
can be detected in 5–week–old human embryos) and it is complete before the 10th 
week of gestation. β–globin expression starts early in human development, β–chain 
synthesis increases to approximately 10% of total Hb by 30–35 weeks of gestation 
(Steinberg et al., 2009). At birth, HbF consist of 60%–80% of the total Hb, with a 
70:30 
Gγ:Aγ ratio (Manca and Masala, 2008). 
HbF takes approximately 2 years to reach the level of 0.5%–1% and is 
restricted to a few erythrocytes called “F cells”: 3%–7% of erythrocytes are F cells 
and each contains approximately 4–8 pg of HbF, with Gγ:Aγ ratio reverted to 40:60. 
Understanding of the control of switching is expected to lead to the 
development of treatments of Hemoglobinopathies (Hbpathies) in which the 
Figure 5 
Switch of non–α globin genes and location of erythropoiesis. 
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production of HbF can compensate for the loss of β–chain activity or can decrease 
imbalance between α:non–α globin ratio (Para. 3.2). 
 
During ontogenetic development, there is a competition between regulatory 
sequences and active globin genes. These competitive interactions are influenced by 
variations in the relative concentrations and/or post–translational modifications of 
transcription factors that are expressed at all developmental stages (Steinberg et al., 
2009). 
Nonetheless, since eukaryotic genes are packaged in the nucleosomes and that 
gene activation is always affected by many factors like the distal regulatory 
sequence, the proximal regulatory element, the chromatin structure and so on, globin 
gene regulation is destined to be very complex, involving intergenic transcription, 
nuclear localization and histone acetylation (Tang et al., 2002). 
 
2.1 Regulatory regions and transcription factors of globin genes 
Promoter regions 
For genes transcription one DNA segment have to interact with RNA 
polymerase II and its accessory factors (such as TFII–D and TFII–B): this DNA 
segment is called basal promoter. 
Five motifs are present in human genes basal promoters: from 5’→3’: BRE 
(–37 nucleotides 5’ to CAP), TATA box (–31 nt), Inr (+1), MTE (+27) and DPE 
(+32); they are also required to drive the transcription of the globin genes (Fig. 6 A) 
(Maston et al., 2006). 
The upstream regulatory region in globin genes runs from approximately 
positions –40 to –250 (Fig. 6 B). Only one motif in this region is found in all the 
highly expressed globin genes: the CCAAT box; proteins such as NF–Y and CP1 
bind to this motif. It is missing from the δ–globin gene (HBD) promoter, but this 
gene is expressed at a low level (∼1%–2% of HBB). 
Two motifs are found in many but not all promoters. One is the CACC box, 
which is bound by transcription factors in the Krüppel–like zinc finger class (KLF). 
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Mutations in almost every position in the proximal CACC box of HBB promoter 
have been associated with β–thalassemia. Other KLFs may bind to the CACC boxes 
in other globin gene promoters, such as FKLF or KLF1366 for the HBG1 and HBG2 
promoters. 
The other motif occurring frequently in upstream regulatory regions is 
WGATAR, the binding site for GATA1 and related proteins. GATA1 plays a 
critical role in both erythroid–specific gene activation and repression. 
Furthermore, a different set of binding sites is distinctive to each type of gene. 
For instance, βDRF60 and BB1–binding protein regulate the β–globin gene but not 
other globin genes (Fig. 6 B). Also, binding of OCT1, SSP and γPE has been shown 







Motifs and binding sites in cis–regulatory modules of globin genes. The boxes were placed in the 
correct order but spacing is not indicated. The thick line for the HBA upstream regions (both HBA1 
and HBA2) denotes that it is a CpG island. 
 
A) Motifs in the basal promoter 
B) Motifs in the regulatory regions immediately upstream of the basal promoters 
(Steinberg et al., 2009) 
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SSP is composed of the ubiquitously expressed factor CP2 and a recently 
cloned protein, NF–E4, which is erythroid specific and activates γ–gene expression 
in transfection experiments in vitro. These studies show that SSE has the ability to 
allow the γ–promoter to function in preference to a linked β–globin gene in plasmid 
constructs containing the HS2 portion of the β–LCR. SSP DNA binding activity 
appears to be relatively restricted to fetal erythroid cells. So, it is believed that  
γ–globin synthesis is stimulated in part by expression of SSP, which impart a 
competitive advantage for recruitment of the β–LCR to the γ–promoter. The SSE, 
however, is neither necessary nor sufficient for competitive inhibition of β–globin 
gene expression in immortalized erythroid cell lines (Steinberg et al., 2009). 
  
Another protein complex with potential roles in globin gene switching is direct 
repeat erythroid definitive (DRED). DRED was isolated through its affinity for 
direct repeat (DR) elements that cluster near the ε–globin and γ–globin promoters. 
DR sequences are of interest because mutations in this region are associated with 
several cases of Hereditary Persistence of Fetal Hb (HPFH, Chap. 4) (Steinberg et 
al., 2009). 
 
The most distinctive globin gene promoters are those of the α–globin genes 
(HBA1 and HBA2). These promoters are CpG islands, and among the Hb genes, 
only those encoding α–globin have this feature. It is still not clear what can prevent 
their expression in non–erythroid tissues and which sequences, in addition to the 
CpG island, lead to very high–level expression in erythroid cells. 
No GATA1–binding site is found in the α–globin gene promoters, so 
sequence–directed binding of this protein to the proximal sequences is not the 
answer. 
Several studies have shown that the CpG island is a key component of the  
cis–regulatory elements for the α–globin gene of humans and rabbits, possibly 
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Enhancers 
An enhancer is a DNA sequence able to increase the activity of a promoter; 
usually it is located on either side of a gene or internal to it (proximal enhancer), but 
it can also be located at significant distances (distal enhancer). 
 
Two proximal enhancers have been found close to genes in the β–globin gene 
cluster, one that is 3’ to HBB (3’HS1) and one that is 3’ to HBG1. In both cases the 
enhancers are less than 1 kb downstream of the poly(A) additional signal for the 
respective genes.  
Both enhancers contain binding sites for GATA1 and the HBG1 enhancer also 





The 3’HS1 enhancer is located downstream from the poly(A) site of the  
β–globin gene. A deletion of sequences between 605 and 895 bp 3’ to the poly(A) 
site, results in a 10 fold reduction in the level of expression of the β–globin gene in 
transgenic mouse. Also, a DNA fragment including β–globin 3’–flanking sequences 
(425–1480 bp from the poly(A) site), in either orientation, activates transcription 
from the otherwise silent 
Gγ–globin promoter in the mouse fetal liver. This enhancer, 
in the region approximately 600–900 bp 3’ to the β–globin poly(A) site, contributes 
to the differential stage–specific expression of the β–globin and Gγ–globin genes 
(Trudel and Costantini, 1987). 
The enhancer located downstream from the 
Aγ gene was identified on the basis 
of transient transfection experiments. This element contains binding sites for various 
transcription factors, but it appears to have no effect on γ–globin gene expression  
in vivo. In transgenic mice, presence of this 3’ element protects the γ gene from 
Figure 7 
Motifs in the proximal enhancers at 3’ Aγ and β (3’HS1). 
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position effects, suggesting that its likely role is stabilization of the interaction 
between the γ–globin gene and the β–LCR (Steinberg et al., 2009). 
Another enhancer has been recently found in intron 2 of the β gene. For  
β–LCR activity, the 5’HS3 element requires the interaction with the AT–rich region 
(ATR) in β–globin IVS2. The ATR consists in an inverted double GATA1 site 
composed of 2 non–canonical sequences (GATT and GATG) and an OCT1 
consensus site (Bharadwaj et al., 2003). 
 
In addition to the TATA and initiator elements, conserved Enhancer box  
(E–box) motifs are located in the β–globin downstream promoter. Previous studies 
showed that E–box–binding proteins can participate in the formation of transcription 
complexes on both TATA–containing and TATA–less genes. 
The downstream promoter region of the human β–globin gene contains three 
E–box motifs (consensus sequence CANNTG). Two of these E–boxes, the one 
overlapping the initiator (+1) and the distal E–box (+60), are conserved in human, 
mouse and rabbit, whereas the E–box located at +20 is only present in the human and 
rabbit genes. 
One of the E–box motifs overlaps the initiator and this composite element 
interacts with USF1 and TFII–I in vitro. It is proposed that in cells not expressing the 
β–globin gene (inactive), TFII–D is not bound and the initiator sequence is occupied 
by protein complexes consisting of TFII–I and USF2. 
Another E–box, located 60 bp 3’ to the transcription initiation site, interacts 
with USF1 and USF2. Mutations of either the initiator or the downstream E–box 
impair transcription of the β–globin gene in vitro. 
Mutation of sequences between the initiator and the E–box at +60 had no effect 
nor did a mutation introduced into the species non–conserved E–box at +20 (Leach 
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Distal enhancers are needed for high–level expression of any gene in the 
linked globin gene clusters. These are the β locus control region (β–LCR) for the  
β–globin gene cluster and HS–40 or major regulatory element for the α–globin gene 
cluster. 
The β–LCR is a very large regulatory region, containing five DNase 
hypersensitive sites (5’– HS5 to HS1 –3’) in humans, extending over 17 kb between 
an OR gene and HBE (Fig. 4 B). The β–LCR is necessary for opening a 
chromosomal domain and chromatin repositioning. Detailed structure and 
mechanism of Hb enhancement mediated by β–LCR can be found in Paragraph 2.2. 
 
The distal enhancer for the α–globin gene, HS–40, is much smaller (250 bp) 
than the β–LCR, and it’s located in a widely expressed gene called C16orf35  
(Fig. 4 A). HS–40 is sufficient for strong enhancement and high activity in erythroid 







Both the β–LCR and the α–globin HS–40 are very strong, erythroid–specific 
enhancers needed for the expression of any of the linked globin genes. 
 
Intergenic regulatory elements 
Studies of cis–linked intergenic regulatory elements that control β–like globin 
gene expression have revealed a variety of motifs that activate or repress the globin 
genes at the appropriate stage of development. These elements include silencers, 




Motifs in distal positive regulator HS–40 for the α–globin gene cluster. 
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Silencers. Silencers bind repressor protein complexes that interfere with 
promoter activity, thereby downregulating gene expression. A silencer located in the 
distal promoter of the ε–globin gene controls autonomous repression of ε–globin 
gene expression during the fetal and adult stages of development (Harju et al., 2002). 
Other silencers can be found in the distal promoter of both 
Gγ– and Aγ–globin gene 







GATA1 and YY1 proteins constitute at least two of the components of the 
repressor complex. 
Transgenic mouse experiments have localized a potential silencer element in 
the –382 to –730 region (Stamatoyannopoulos et al., 1993). That the −382 to −730 
region may contain a silencer has also been shown by the finding of an HPFH 
mutation at position −567 that alters GATA1 binding (Chen et al., 2008; Steinberg et 
al., 2009). 
 
Insulators. Insulator elements protect against the negative effects of 
neighboring heterochromatin and may serve as boundary elements (See Below) that 
flank or demarcate an open, transcriptionally active chromatin domain. Insulator 
elements may block histone deacetylase activity. The human β–LCR has itself 
insulator properties. Insulators facilitate the activity of enhancers located within an 
open chromatin domain. 
 
MARs/SARs. Matrix attachment regions (MARs) or scaffold attachment regions 
(SARs) are elements that promote binding to the nuclear matrix, resulting in the 
formation of contiguous DNA sequence loops. These elements may provide a barrier 
Figure 9 
Schematic representation of the position of Silencer elements on the 
β–globin gene cluster. 
 
 
 .................................................................................................................................. INTRODUCTION 
Sandro Trova 
Analysis of genetic determinants associated with Persistent Synthesis of Fetal Hemoglobin 
PhD Thesis in Biomolecular and Biotechnological Sciences (Biochemistry and Molecular Biology) 
 Università degli Studi di Sassari 
20 
by shielding the locus from the effects of surrounding negative chromatin or provide 
a structural restraint to chromatin remodeling. 
 
Boundary Elements. Boundary elements may be located at various positions 
within a locus and may assume a restrictive role regarding gene expression when 
associated with binding proteins. Three properties may be characteristic of boundary 
elements: 1) possible association with insulators, 2) maintenance of a steady state 
between open and closed chromatin, and 3) presence of terminal domain sequence 
elements and binding proteins. Boundary elements have been defined as sequences 
that isolate specific chromatin domains. They contain cis–acting elements that have a 
positive influence within the domain and prevent chromatin influence from outside 
the domain. (Harju et al., 2002) 
 
2.2 The β–Globin Locus Control Region (β–LCR) role in  
globin expression 
β–LCR is located 6–25 kb upstream from the ε–globin gene and contains a 
series of developmentally stable DNase I hypersensitive sites (5’– HS5 to HS1 – 3’). 
A large number of studies indicates that the activities of the β–LCR are mostly 
localized to the core elements of the HS, which are approximately 300 bp long, 
where transcriptional factors bind. Nonetheless, the regions flanking the HS elements 
of the β–LCR are also important for function. 
Three transcription factor binding motifs are present in almost all HS: Maf–
response elements (MAREs) to which transcriptional activator proteins of the basic 
leucine zipper class can bind (e.g. NFE2, LCRF1/Nrf1, and Bach1); GATA motifs, 
to which GATA1 and its relatives bind; CACC, to which a family of Zinc–finger 
(EKLF, Sp1) can bind (Steinberg et al., 2009). 
HS2, the strongest enhancer of the β–globin β–LCR, like HS–40, have two 
MAREs without which enhancement is strongly decreased (Caterina et al., 1994). 
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HS2 also has three E–boxes, where TAL–1 and its partners bind. This protein 
involved in regulation of hematopoiesis, appears to be a key for enhancement by 
HS2 (Elnitski et al., 1997). 








A study by Fraser et al., 1993 showed that the HS of the β–LCR have 
developmental specificity. Other experiments on transgenic mice confirmed this 
hypothesis. For example deletion of the core element of HS3 results in total absence 
of ε–globin gene expression in day–9 embryonic cells, while γ–gene expression in 
embryonic cells is normal, suggesting that HS3 is necessary for activation of  
ε–globin gene transcription. However, γ–globin gene expression, is totally absent in 
fetal liver cells, indicating that the core of HS3 is necessary for γ–gene transcription 
in the fetal stage of definitive erythropoiesis (Steinberg et al., 2009). 
Individual function of each HS linked to reporter gene is summarized in  
Table I (Harju et al., 2002). 
 
Some uncertainty still exists regarding the direct effects of the β–LCR on 
chromatin conformation. For example experiments have been recently indicated that 
the β–LCR is not required for opening the chromatin domain in knockout mice, in 
contrast to what happens in humans. While in (εγδβ)–thalassemia mutants due to  
β–LCR deletions there is total inactivation of the β–locus chromatin and total 
absence of transcription of the β–cluster genes in cis, when the β–LCR is deleted 
from the endogenous murine β–LCR, the globin genes continue to show some low 
Figure 10 
Motifs in distal positive regulator: HSs of the β–LCR. 
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levels of expression, and the chromatin of the locus remains in the open 
configuration. Why β–LCR deletions in humans and the β–LCR knockouts in mice 
phenotype is different is still unknown. 
A possible reason may be due to the differences in the composition and 
organization of the murine and the human β–LCRs. Alternatively, the total silencing 
of the locus in the human β–LCR deletions might not be caused by the deletion of the 
β–LCR per se, but the juxtaposition to the locus of heterochromatic regions, located 
upstream, that silence the genes of the locus (Steinberg et al., 2009). 
 
One of the main questions in transcriptional regulation is how cis–regulatory 
elements communicate with the promoter of a gene over large distances. 
Four different models (Fig. 11) were proposed to explain the functions of  
β–LCR and provide evidences that the HSs of β–LCR act either independently or 
synergistically. Other than these models, chromatin remodeling, topologic alterations 
and modifications of proteins associated with the chromatin are also involved in the 
















Models for β–LCR mechanism of enhancement. 
(Kukreti et al., 2010) 
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The “looping model” was first proposed by Choi and Engel, 1988, who 
suggested that the distal and proximal regulatory elements could interact directly by 
the formation of a loop. Each HS of the β–LCR does not function alone. The factors 
bound to each of the β–LCR HSs contribute cooperatively to form a larger physical 
entity termed the “holocomplex”. 
The HS core elements in fact bind transcription factors and the core–flanking 
sequences constraining the holocomplex in the proper conformation (Tang et al., 
2002). This structure loops so that the β–LCR comes in close proximity and 
associate with proximal promoter and enhancer elements of the gene. This allows  
the delivery of β–LCR–bound transcription proteins to interact with the basal 
transcription apparatus, already bound at the promoter to form a stable transcription 
complex, thus enhancing globin gene expression. 
A variation of this model sees β–LCR as a multiple element receptor, where 
chromatin remodeling factors bind. After completion of chromatin–remodeling 
activity, the β–LCR can directly interact with downstream genes and facilitate their 
expression (Kukreti et al., 2010).  
HS sites at the β–LCR are required to 
form a unique 3–dimensional structure at the 
chromosomal location of the β–globin locus 
on chromosome 11, with “looping out” of 
the locus in a unique spatial configuration, 
an active chromatin loop at the β–globin 
locus, termed an “active chromatin hub” 
(ACH). The β–ACH includes the β–LCR 
sequences, interacting with downstream 
globin genes and intergenic sequences, 
transcriptional factors, and chromatin remodeling elements necessary for globin gene 
expression and Hb switching in a special compact configuration (Fig. 12). 
The β–ACH structure is not found in non–erythroid cells (Bank, 2006). 
Figure 12 
Two–dimensional representation of the 3–D 
interactions between the HSs and the globin 
genes in erythroid cells, forming the so called 
Active Chromatin Hub (ACH). 
(Patrinos et al., 2004) 
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The “tracking model”, also called “scanning model”, suggests that 
transcription factors and cofactors bind to recognition sequences in the β–LCR 
sequences, forming an activation complex that migrates, or tracks, linearly along the 
DNA helix of the locus. When this transcription complex encounters the basal 
transcription machinery located at the correct promoter according to the 
developmental stage, the complete transcriptional apparatus is assembled and 
initiation of transcription of that gene takes place. The choice of which gene has to 
be transcribed is mediated by histon deacetylase and methylase proteins within the 
complex, after the transcription is activated: it is supposed that this mechanism can 
limit activation to a particular developmental stage. 
 
In “facilitated–tracking model” aspects of both the looping and tracking 
models are incorporated. Some transcription factors bind 5’HS of β–LCR, which 
loops to contact in promoter–distal regions of downstream DNA. There, the 
transcription factor complex is released and tracks along the chromatin until a stable 
loop structure is established and gene expression proceeds (Kukreti et al., 2010). 
  
The “linking model” proposes that gene activation is the product of sequential 
stage–specific binding of transcription factors and chromatin “facilitators” 
throughout the locus to form an array of chromatin elements that initially define the 
domain to be transcribed. 
For example, when the chain reaches the γ–globin promoter in human fetal 
liver, the facilitator enhances binding of the transcription factors that activate  
γ–globin gene expression. The regulatory protein also acts with the boundary 
elements as a boundary to inhibit further chain extension. Therefore, the downstream 
β–globin gene is inactive. When the boundary function of the promoter is absent, the 
complex at this proximal promoter may actually function as another link in the chain. 
The current gene is inactivated and the following one is activated. 
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In this view, the interaction between β–LCR and individual promoters is 
mediated by a chain of complexes containing transcription factors and chromatin 
facilitators. 
Moreover, non–DNA–binding facilitator proteins form a continuous protein 
chain from the β–LCR to the globin gene to be transcribed (Tang et al., 2002). 
 
There has been a debate in recent years whether this communication between 
β–LCR and β–cluster takes place via a non–contact mechanism (linking, tracking) or 
via a contact mechanism (looping). Although it is now firmly established that 
looping takes place within the β–globin locus (and other loci), it is still not clear how 
these long–range contacts are established and what the precise role of the β–LCR is. 
(Palstra et al., 2008) 
 
2.3 Chromatin role in β–like globin gene expression:  
the PYR role 
Studies have not only focused on the interactions of trans–acting factors and 
cis–acting elements including the β–LCR, but also on remodeling of chromatin. 
Moreover, topologic alterations and modifications of proteins associated with the 
chromatin are concomitant with the β–LCR’s function. These modifications directly 
or indirectly imply the ability of β–LCRs to alter chromatin configuration and 
conformation. 
The exact molecular mechanism of gene expression during human 
development is still not fully understood. It is unclear the mechanism by which the 
β–LCR changes the chromatin conformation throughout the entire β–globin gene 
cluster (Kukreti et al., 2010). 
 
Acetylation of histones in chromatin leads to increased expression of specific 
genes at structural gene loci, including the β–globin locus, by making gene 
sequences more available to transcription factors. Specific acetylations of histones 
H1–H8 in chromatin can be achieved either by histone acetylase enzymes (HAs) 
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alone or by ATP–driven molecular machines providing this function, such as 
SWI/SNF complexes. 
By contrast, deacetylation of histones in chromatin by histone deacetylases 
(HDACs), can repress and silence specific gene function at many loci and may be 
involved in repressing human γ–globin gene expression. 
Other enzymatic complexes can also modify histone N–terminal tails by 
methylation, phosphorylation, and ubiquitination as well (Bank, 2006). 
 
Bank group has described a chromatin remodeling complex called PYR 
complex found only in adult hematopoietic cells. It is a single complex with Ikaros 
(its DNA–binding subunit) and contains both positive–acting protein subunits of the 
SWI/SNF complex that activate gene transcription and repressive protein subunits of 
the NURD complex, an HDAC–containing complex that can repress transcription. 
PYR complex binds to a 250–bp polypyrimidine (PYR)–rich DNA sequence  
1 kb upstream of the human δ–globin gene; the PYR complex DNA–binding site is 
deleted in the HPFH–2, but not in the Sicilian δβ–thalassemia (Para. 4.1, Fig. 18). 
Deletion of 511 bp of DNA including the PYR binding site upstream of the human 
δ–globin gene delays human γ to β switching in mice. 
PYR complex has a role in normal human γ to β switching, and that perhaps 
inhibition of PYR complex action, for example, by siRNA inhibition of Ikaros 
activity, may be an additional therapeutic approach to reactivation of γ–globin in 
adult erythroid cells. 
 
PYR role in Hb switching has been proposed: during fetal life, the γ–globin 
genes associate with the β–LCR through erythroid and fetal stage–specific 
transcription factors, and with putative embryonic–fetal stage–specific chromatin 
remodeling complexes, to favor γ–globin transcription. 
In adult cells, the β–ACH configuration is changed so that the β–LCR now 
preferentially associates with and activates human β–globin gene expression. 
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To induce conformational changes at the  
β–globin locus in adult–type cells it has been supposed 
an adult stage–specific formation and action of the PYR 
complex, by binding to the intergenic γ–δ sequences at 
the PYR–binding site and repressing γ–globin 
transcription by its HDACs. The SWI/SNF subunits of 
PYR complex may be involved as well. All of these 
proposed roles for PYR complex must await 
confirmation by further studies of the role of Ikaros and 





2.4 Summary on the fetal to adult switch 
One of the most interesting characteristics of human Fetal to Adult Hb 
switching is its perfect control and the continuation of synthesis of small amounts of 
HbF in the adult. 
The most accepted explanation comes from the observations made in 
transgenic mice carrying either the γ– or the β–globin gene or both genes linked to 
the β–LCR. When the genes were alone, developmental control was lost. When the 
genes were linked together, developmental control was restored. Such findings led to 
the proposal that the γ–globin gene is regulated through competition with the  
β–globin gene and vice versa. 
The hypothesis is that in the embryonic stage, the β–LCR interacts with the  
ε–globin gene; the downstream genes are being turned off competitively. In the fetus, 
the ε gene is silenced due to its Silencer element, and the β–LCR interacts with the 
Gγ and Aγ genes. In the adult, the γ genes are silenced, and the β–LCR can now 
interact with the β–globin gene, the last gene of the locus. The closer the gene, the 
higher is the advantage. Its placement at the 3’ end of the locus might explain why 
Figure 13 
The proposed role of the PYR 
complex in human hemoglobin 
switching. 
(Bank, 2006)  
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the adult genes are totally shut off in embryonic cells when it is located in its normal 
chromosomal position, whereas it 
is always expressed in the embryo 
if it is placed next to the β–LCR 
(Fig. 14). 
In addition to the cis–acting 
elements already described, also 
the trans–acting factors such as 
EKLF, GATA1, its cofactor FOG1, 
and perhaps other factors of the 
KLF/SP1 family are likely to 
facilitate the formation of the loop 
between the β–LCR and the γ– or 







Model of the competitive control of hemoglobin 
switching. “S” indicates the activity of a silencer 
element. 
(Steinberg et al., 2009) 
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3. CLASSIFICATION OF THE DISORDERS OF HB 
To 2013, more than 1000 disorders of Hb synthesis and/or structure have been 
identified and characterized: each one can lead to a distinct clinical phenotype. 
Genotype/phenotype correlations have provided important understanding of 
pathophysiological mechanisms of disease in the disorders of Hb. 
 
 Hb disorders can be classified into two general categories (listed in detail in 
Table II A and B): 
 
A. Thalassemia Syndromes or Quantitative Hemoglobinopathies in which there 
is a quantitative defect in the production of one of the globin subunits, either 
total absence or marked reduction.  
B. Qualitative Hemoglobinopathies in which a structural defect on the gene 
alters the primary structure of the globin (Forget and Bunn, 2013). The amino 
acid substitution may be phenotypically silent or change the properties of the 
tetramer, resulting in differences in stability, O2 affinity and other functions of 
the Hb. 
 
3.1 The Thalassemia syndromes 
The thalassemia syndromes are inherited disorders characterized by absence or 
markedly decreased accumulation of one of the globin subunits of Hb. Thalassemia 
was first defined by Dr. Thomas B. Cooley in 1925 at the annual meeting of the 
American Pediatric Society where he presented five young children with severe 
anemia, splenomegaly and bone abnormalities (Weatherall, 2010). 
In the α–thalassemias, there is absent or reduced production of α–globin 
whereas in the β–thalassemias, there is absent or decreased production of β–globin. 
Rare thalassemias affecting the production of δ– or γ–globin subunits have also been 
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3.1.1 α–thalassemias 
In contrast to the β–thalassemias, which are usually caused by point mutations 
of HBB (Para. 3.1.2), the α–thalassemia syndromes are usually due to the deletion of 
one or more α–globin genes. Several different point mutations cause the less 
common non–deletional forms of α–thalassemia (αTα/αα). 
 
α–thalassemias are subclassified according to the number of α–globin genes 
that are deleted (or mutated): 
 α+–thalassemia: one gene deleted (–α/αα); 
 α0–thalassemia: two genes deleted (–α/–α or – –/αα); 
 HbH disease: three genes deleted (– –/–α); 
 Hydrops fetalis with Hb Bart’s: four genes deleted (– –/– –) 
(Forget and Bunn, 2013). 
 
In α–thalassemia, the synthesis of α–globin chains is downregulated so that in 
fetal life there is anemia and the excess γ–globin chains form soluble tetramers (γ4) 
called Hb Bart’s. In adult life, α–thalassemia also causes anemia but, because by this 
time the γ to β switch is complete, the excess non–α chains assemble into β4 
tetramers, called HbH. The degree of anemia and the amounts of the abnormal Hbs 
produced (Bart’s and H) reflect the degree to which α–globin synthesis has been 
downregulated (Steinberg et al., 2009). 
In contrast to β–thalassemia minor, HbA2 levels do not raise, so its 
identification is based mainly on hematological parameters (Para. 3.1.2). 
Clinically, the deletion of only one of the four α–globin genes is not associated 
with significant hematologic abnormalities and is sometimes called the “silent 
carrier”. 
The deletion of two α–globin genes can occur on the same chromosomes (in 
cis) or on opposite chromosomes (in trans). The clinical phenotype is similar with 
both genotypes and consists of mild hypochromic, microcytic anemia, without 
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hemolysis, somewhat analogous to that of β–thalasssemia trait (Para. 3.1.2), but 
somewhat less severe (Forget and Bunn, 2013). 
These genotypes (–α/αα and – –/αα or –α/–α) may produce detectable amounts of Hb 
Bart’s at birth. In addition, occasional cells containing HbH may be detected in 
adults with the – –/αα genotype (Steinberg et al., 2009). 
The deletion (or significantly decreased expression) of three α–globin genes is 
associated with the syndrome of HbH disease, a compensated hemolytic anemia that 
usually does not require treatment by RBC transfusion. However, HbH is relatively 
unstable and does precipitate as RBCs age, forming inclusion bodies that damage 
RBCs and shorten their lifespan. 
The deletion of all four α–globin genes is usually fatal during late pregnancy or 
shortly after birth. This condition is called hydrops fetalis with Hb Bart’s: this 
homotetramer has a very high O2 affinity, similar to that of myoglobin, and does not 
release O2 to the tissues under physiologic conditions. Consequently, the infant, 
whose RBCs lack HbF or HbA and contain mostly Hb Bart’s, suffers severe hypoxia 
resulting in hydrops fetalis. Rare cases have been rescued by intrauterine 
transfusions, but these children subsequently require lifelong transfusion support 
similar to that required by children with β–thalassemia major (Forget and Bunn, 
2013). 
 
The molecular cause of deleted alleles is explained by DNA sequence analysis: 
the α–globin genes are embedded within two highly homologous, 4–kb duplication 
units whose sequence identity appears to have been maintained throughout evolution 
by gene conversion and unequal crossover events. These regions are divided into 
homologous subsegments (X, Y, and Z) by non–homologous elements (I, II, and III). 
Reciprocal recombination between Z segments (Fig. 15 A), which are 3.7 kb 
apart, produces chromosomes with only one fusion α–gene (α–3.7, rightward deletion) 
and chromosomes with three α–genes (αααanti 3.7). 
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Recombination between homologous X boxes, which are 4.2 kb apart, also 
gives rise to an α–thalassemia determinant (α–4.2, leftward deletion) (Fig. 15 B) and a 
αααanti 4.2 chromosome. 
 
A) Rightward Crossover B) Leftward Crossover 
 
 
Further recombination events between the resulting chromosomes may give 
rise to quadruplicated and quintuplicated α–genes (ααααanti 3.7, ααααanti 4.2). 
Normal individuals with 4, 5 or 6 α–genes have been described: although there 
appears to be an excess of α–mRNA and α–globin produced from the ααα 
arrangement homozygotes (ααα/ααα) they are still hematologically normal 
(Hematological reference values can be found in Table III). While it has not been 
formally analyzed in human, in sheep it has been shown that the efficiency with 
which multiple α genes are expressed decreases from the 5’ to 3’ position on the 
chromosome. In this case, as more α genes are added to the cluster (αα to ααα to 
αααα), any increase in α–globin expression may be less than expected from the 
addition of fully expressed extra genes (Steinberg et al., 2009). 
 
In addition to these forms of α–thalassemia inherited with Mendelian genetics, 
there are two α–thalassemia syndromes that are caused by de novo or acquired 
mutations affecting expression of the α–globin genes: 1) the α–thalassemia with 
Figure 15 
The mechanism by which the common deletions underlying α+–thalassemia occur.  
 
A) Rightward Crossover between misaligned Z boxes give rise to the α–3.7 and αααanti 3.7 chromosomes 
B) Leftward Crossovers between misaligned X boxes give rise to α–4.2 and αααanti 4.2 chromosomes 
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mental retardation syndrome (ATR); and 2) acquired α–thalassemia (HbH disease) 
associated with myelodysplastic syndromes (ATMDS) (Forget and Bunn, 2013).  
 
3.1.2 β–thalassemias 
The β–thalassemias can be subclassified into those in which there is total 
absence of normal β–globin subunit synthesis or accumulation, the β0–thalassemias, 
and those in which some structurally normal β–globin subunits are synthesized, but 
in markedly decreased amounts, the β+–thalassemias (Forget and Bunn, 2013), with 
the mildest forms sometimes referred to as β++ or “silent” β–thalassemia. These 
common forms of β–thalassemias are inherited as mendelian recessives (Steinberg et 
al., 2009). 
The molecular basis of the β–thalassemias is very heterogeneous (Thein, 
2013): more than 200 β–thalassemia alleles have now been characterized 
(http://globin.cse.psu.edu) involving mutations that affect the transcription of the  
β–globin gene, post–transcriptional processing of its pre–mRNA, or the translation of 
its mRNA into protein (Forget and Bunn, 2013). 
Some structurally abnormal β–chain variants are also associated with 
quantitative deficiencies of β–globin chain production and have a phenotype of  
β–thalassemia, in which case they are referred to as “thalassemic 
Hemoglobinopathies” (e.g. HbE β(26) Glu→Lys). 
In other structural variants, the mutated β–globins are so unstable that they 
undergo very rapid post–synthetic degradation. These hyperunstable β–chain variants 
act in a dominant negative way, causing a disease phenotype even when present in 
the heterozygous state, and hence have been referred to as “dominantly inherited  
β–thalassemia” (Steinberg et al., 2009). 
 
Usually, the mutations causing β–thalassemia are point mutations affecting a 
single nucleotide, or a small number of nucleotides, in the β–globin gene (Forget and 
Bunn, 2013).  
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One of the first mutations to be characterized and extensively studied is the 
nonsense mutation at codon 39 (CAG→TAG). This mutation is one of the most 
common cause of β–thalassemia in the Mediterranean population and accounts for 
most of the cases of β–thalassemia in Sardinia (See “Aim of this study”) (Steinberg 
et al., 2009). 
Rare deletion forms of β–thalassemia have also been described. These deletions 
are usually caused by “unequal” crossing over between the linked and partially 
homologous genes like δ– and β–globin genes, resulting in either the loss of genes or 
the formation of a fusion δβ–globin gene (e.g. δβ hybrid Lepore). 
Large deletions involving part or all of the β–globin gene cluster are 
responsible for the δβ–thalassemias, the εγδβ–thalassemias, and HPFH syndromes 
(Para. 4.1). 
The εγδβ–thalassemias are associated with neonatal hemolytic anemia, but this 
resolves during the first few months of life and the associated phenotype in adults is 
that of β–thalassemia trait (See Para. 3.2) (Forget and Bunn, 2013). 
 
β–thalassemias caused by point mutations were among the first human genetic 
diseases to be examined through recombinant DNA analysis: it showed the existence 
of multiple restriction site polymorphisms within the β–globin gene cluster and it 
allowed the detailed characterization of chromosome regions in which mutant  
β–globin genes reside. 
The coupling of specific mutations and haplotypes is an example of linkage 
disequilibrium in which specific alleles become associated with neutral changes in 
the DNA (SNPs): this means that haplotypes can be coupled with a series of specific 
mutations on β–globin gene (Orkin et al., 1982). 
One of the first observations on the β–cluster was made by Orkin who 
performed combined analysis of DNA polymorphisms in the human β–globin  
gene cluster and in cloned β–gene, revealing the association of specific  
β–thalassemia mutations and β–gene SNPs with particular flanking polymorphism.  
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Nine different cleavage patterns were observed and designated haplotypes I to 
IX: in this Thesis they will be referred as Orkin haplotypes. Polymorphic restriction 
enzyme sites in the β–globin gene cluster and relative haplotypes are shown in  
Fig. 16. Their position on the β–cluster can be found in Paragraph 8.1. 
 
These haplotypes are coupled with specific β–thalassemia defects: this 
indicates the presence of a specific mutant alleles carrying a mutation within  
β–globin gene. For example, the codon 39 mutation was identified on haplotype II 
(24% of Italians β0(39) chromosomes) as well as haplotype IX (5%) (Orkin et al., 
1982). 
Additionally, sequencing of β–globin gene revealed five SNPs: the 
synonymous mutation C→T at codon 2 (His→His) (See Para. 2.1 “Enhancers” for 
more information), and four SNPs in IVS2 (+16C→G or Ava II − → +), +74G→T, 
+81C→T and +666T→C). These SNPs indicated the existence of three β–globin 
gene frameworks: 
Figure 16 
Polymorphic restriction enzyme sites in the β–globin gene cluster.  
+ indicates the presence of cleavage at a particular site, and  indicates absence  
of cleavage. Haplotypes indicate the patterns of cleavage along a chromosome and 
are numbered I to IX. 
(Orkin et al., 1982) 
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- Type 1 is characteristic of β–genes of haplotypes I, II and IX and show the 
same nucleotides as reference sequence (CCGCT), in the same order 
described above 
- Type 2 β–gene present in haplotypes III, V and VIII and have a single 
substitution at IVS2 +74 (CCTCT) 
- Type 3 genes encompass haplotypes IV, VI and VII and display all five 
polymorphisms (TGTTC) (Orkin et al., 1982). 
 
3.2 Pathophysiology and phenotypes of β–thalassemia  
To reach the right corpuscular Hb concentration it is essential that α–globin as 
well as β–globin (or γ–globin) mRNA are expressed at very high levels and very 
closely matched: in fact free α–globin subunits are particularly toxic to erythroid 
cells. This problem is physiologically overcome by the presence of α–Hb stabilizing 
protein (AHSP), a chaperone that is expressed at high levels in erythroid cells and 
binds tightly to heme–intact α–globin subunits. The AHSP protects the cell from 
potentially toxic oxidized (Fe
3+
) heme until it is reduced to functional Fe
2+
 heme. 
When α/AHSP dimer encounters a β–globin subunit, the α–globin dissociates from 
AHSP to form the extremely stable αβ dimer. This process is facilitated by 
electrostatic attraction between positively charged α–globin subunits and negatively 
charged β–globin subunits. 
 
Mutations of globin genes, that impair synthesis or some that alter the structure 
of globin subunits, give rise to thalassemia and anemia of varying degree (Forget and 
Bunn, 2013). Also, altered AHSP expression levels or AHSP variants could 
modulate the severity of β–thalassemia in humans (Kong et al., 2004). 
 
According to the severity of the phenotype, β–thalassemias can be  
subclassified in three different groups having different degrees of biosynthetic 
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 β–thalassemia trait or β–thalassemia minor (Tm) (heterozygotes for a 
defective β–gene). Heterozygotes have minimal anemia, but hypochromic 
(mean corpuscular Hb [MCH] 18–24 pg), microcytic (mean corpuscular 
volume [MCV] 65–80 fl) red blood cells (Hematological reference values can 
be found in Table III). They are characterized by an increased proportion of 
HbA2 (normal <3.2%, β–thalassemia trait 3.5%–6.0%), and HbF levels that 
vary from normal (<1.0%) to slightly raised (1.0%–3.0%) (Forget and Bunn, 
2013). Most cases of normal HbA2 in β–thalassemia trait result from 
coinheritance of δ–thalassemia in cis or trans to a β–thalassemic gene 
(Steinberg et al., 2009), or for the presence of the −196 C→T ndHPFH 
mutation on HBG1 gene, which may compete for transcriptional factors shared 
with HBD gene (Loudianos et al., 1992). 
 β–thalassemia major or Cooley anemia (TM) (homozygotes or compound 
heterozygotes), are characterized by a severe transfusion–dependent hemolytic anemia 
associated with marked ineffective erythropoiesis resulting in destruction of erythroid 
precursor cells in the bone marrow (Forget and Bunn, 2013). 
 β–thalassemia intermedia (TI) is a less common clinical phenotype. It was 
first termed Thalassemia Intermedia by Sturgeon to describe the patients who 
had “clinical manifestations that are too severe to be termed minor and too mild 
to be termed major” (Sturgeon et al., 1955). TI is characterized by Hb levels 
maintained around 7–10 g/dl, by more severe red blood cell (RBC) 
abnormalities than Tm, by a varying degree of spleen enlargement, and by 
skeletal changes such as expansion of facial bones and obliteration of maxillary 
sinuses which causes protrusion of the upper jaw. Also TI accumulate iron due 
to increased intestinal iron absorption and reduced expression of hepcidin, a 
hepatic peptide that plays a central role in iron homeostasis (Taher et al., 2009). 
TI patients show a moderate to severe, partially compensated, hemolytic 
anemia that usually does not require chronic transfusion therapy to maintain a 
satisfactory circulating Hb level in the affected patient, although occasional 
transfusions may be required if the anemia worsens because of associated 
complications (Forget and Bunn, 2013). 
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Such TI patients have a milder disease because there is less severe α– to  
non–α–globin subunit imbalance than in typical β–TM patients, resulting in less 
accumulation of free α–subunits that cause the ineffective erythropoiesis. 
There are different possible causes for such a lowered α– to non–α–globin 
subunit imbalance, including: 
 inheritance of milder β+–thalassemia mutations with less severe than usual 
deficiency of β–globin subunit production; 
 coinheritance of a form of α–thalassemia (contrary ααα/αα or αααα/αα 
genotype exacerbates TI); 
 coinheritance of determinants associated with increased production of the  
γ–subunit of HbF (Chap. 4). 
 
Most patients with TI carry two mutant β–globin genes: they have a genotype 
typical of TM, but the phenotype is modified by one of the factors listed above. 
However, rare cases of TI are caused by heterozygosity for a single mutant  
β–globin gene associated with the production of a highly unstable β–globin subunit 
(dominant β–thalassemic allele) (Forget and Bunn, 2013).  
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4. PERSISTENCE OF FETAL HEMOGLOBIN 
Sickle cell disease (SCD) and β–thalassemia are among the most common 
genetic diseases worldwide and have a major impact on global health and mortality. 
Both these Hbpathies display a remarkable diversity in their disease severity. A 
major ameliorating factor is an innate ability to produce HbF. 
HbF levels vary considerably, not only in patients with β–Hb disorders, but 
also in healthy normal adults. 
Although the majority of adults have HbF of less the 0.6% of total Hb, 10–15% 
of individuals have increases ranging from 0.8% to 5%. The latter individuals are 
considered to have heterocellular hereditary persistence of fetal Hb (hHPFH), which 
refers to the unequal distribution of HbF among the erythrocytes. 
When coinherited with β–thalassemia or SCD, hHPFH can increase HbF 
output to levels that are clinically beneficial (Thein et al., 2007). 
 
Some other molecular conditions lead to pancellular HPFH: heterozygotes 
show essentially normal red cell indices, a normal level of HbA2 and higher levels of 
HbF (15%–30%) with a more homogeneous, pancellular distribution (Steinberg et 
al., 2009). 
HPFH homozygotes can express up to 100% of HbF (Thein and Craig, 1998) 
in RBC and are clinically normal, although with reduced MCV and MCH indices. 
 
cis–acting variants explain some of the variability in HPFH and include 
mutations on the promoter of γ genes, large deletions on the β–globin gene cluster 
and polymorphic associations within the β–cluster. 
Many cis–acting forms of persistence of HbF are due to gene deletions and are 
classified as either deletional HPFH (dHPFH) or δβ–thalassemia (Para. 4.1). 
In other cis–acting forms HbF levels are influenced by a SNP in the promoter 
region of HBG1 and HBG2 genes, which affect gene expression of either the single 
gene or both γ–globin genes (non–deletional HPFH, ndHPFH) (Para. 4.2) (Steinberg 
et al., 2009). Both deletional and non–deletional conditions are also referred in 
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OMIM database as Fetal Hb Quantitative Trait Locus 1 (HBFQTL1, entry 
#141749). 
 
Furthermore, polymorphic configurations within the β–cluster (in cis) have 
been associated with variability in HbF levels in sickle cell anemia and  
β–thalassemia: they include an (AT)x(T)y polymorphism upstream of the HBB 
promoter, SNPs upstream of the 
Gγ gene (pre–Gγ framework) and in Gγ IVS2, and a 
(AT)xN12(AT)y polymorphism within the HS2 element of the β–LCR (Steinberg et 
al., 2009). 
There are many studies addressing the association of these SNPs or 
microsatellites with a specific β–thalassemia gene. It was shown as, sometimes, a 
mutation can be located on two or more different configurations and how these can 
act differently on the phenotype of the patient. 
An example has been shown in a work by De Angioletti et al., 2004: the study 
was carried out in 17 patients, compound heterozygotes for the β–thalassaemia 
mutation β+(−87) C→G, who showed two different phenotypes and two distinct 
haplotypes linked to the β–thalassemic mutation. In fact, the β+(−87) was found 
associated with both Orkin haplotype VIII (β+(−87)/VIII) and V (β+(−87)/V). The 
patients with the β+(−87)/VIII showed milder clinical conditions, with significantly 
higher levels of Hb and HbF and higher synthesis of 
Gγ than the patients with the 
β+(−87)/V. 
The two groups differed not only in the Orkin haplotype associated with the β+(−87) 
mutation, but also in the polymorphic configuration of SNPs and microsatellites on 
β–globin gene cluster. A schematic representation of these associations can be found 
in Fig. 17. 
Two mechanisms could account for the increased HbF synthesis. One is 
present in all patients: the mutation β+(−87) per se reduces the binding of 
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The other mechanism is active only in patients with β+(−87)/VIII and could be 
ascribed to the rare configuration of polymorphisms typical of this chromosome. It is 
still unclear whether only some polymorphisms or the entire configuration are 
involved in the HbF increase. The high increase of the HbF, mostly of the 
Gγ–type, 
strongly suggest the hypothesis that the −158 Gγ Xmn I + plays a principal role and 
that the other polymorphisms could exert a cooperative role in the modulation of 
HbF in patients with erythropoietic stress (De Angioletti et al., 2004). 
By the way, in none of known similar cases there is direct evidence from 
functional studies that different alleles at these sites bring to altered γ gene 
expression; it is possible that these are markers in linkage disequilibrium with as yet 
unidentified elements (Steinberg et al., 2009). 
 
It is noteworthy that the cis–acting variants can explain less than half of the 
cases of persistence of HbF: >50% of the variance is in fact unlinked to the β–globin 
cluster (Thein et al., 2007). 
The loci that increase γ gene expression are clearly not linked to the β–globin 
cluster as they segregate independently of the β–globin gene cluster, with genetic 
heterogeneity and incomplete penetrance. Examples of autosomal, sex–linked, 
dominant, codominant, or recessive patterns have all been reported. These are due to 
quantitative trait loci (QTL) localized to chromosomes 2, 6, and 8 and another that 
Figure 17 
Schema of the cluster of the β–globin genes and of the two haplotypes and polymorphic 
configurations (lower line) found associated with the β+(–87) C→G mutation.  
The polymorphic microsatellite in the 
Gγ and Aγ IVS2 were reported as in Lapoumeroulie et al., 1999: 
GA = (TG)11(CG)3, GB = (TG)19(CG)2CACG, AA = (TG)13. 
(De Angioletti et al., 2004) 
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appears to be X–linked. Additional genes are known to occur but have yet to be 
localized. The mechanism by which the chromosome 2–, 6–, 8–, or X–linked genes 
affect HbF levels and F cells remains mostly unknown. It is possible that these loci 
encode for trans–acting factors that bind within the β–globin gene cluster and affect 
gene transcription (Steinberg et al., 2009). 
 
4.1 dHPFH and δβ–thalassemias (HBFQTL1) 
In both the 
GγAγ(δβ)0–HPFHs (or simply deletional HPFH, dHPFH) and the 
GγAγ(δβ)0–thalassemias (shortly δβ–thalassemias) the deletions remove both the δ 
and β genes and extend a variable degree 3’ to the cluster, in some cases for up to 
100 kb. The 
Gγ(Aγδβ)0–thalassemias differ in that the 5’ end of the deletion partially 
or totally removes the 
Aγ gene in addition to the δ and β genes. 
The broad classification of the deletion conditions into three groups, although 
useful, is rather arbitrary: in fact there is a continuum between δβ–thalassemia and 
the HPFHs and that not all conditions fit neatly into one of these groups. 
dHPFH and δβ–thalassemia were originally distinguished on hematological 
and clinical grounds. Heterozygous δβ–thalassemia had a similar red cell picture to 
β–thalassemia, with hypochromic and microcytic erythrocytes, but a normal level of 
HbA2 (<3.0%). In addition, there was a raised level of HbF (5%–15%) that had a 
heterogeneous intercellular distribution. 
On the contrary, dHPFH heterozygotes, showed normal RBC indices, with an 
homogenous intracellular distribution. 
As more and more cases and different molecular types of the two conditions 
were described, these differences became indistinct and it is now clear that there is 
considerable overlap in many of the parameters that were initially used to 
differentiate them. 
 
Most deletions are due to illegitimate recombination between minimal 
homology of a few nucleotides at the breakpoints. Most show clean breakage and 
reunion, although in some cases a few “orphan” nucleotides of unknown origin have 
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been inserted. Several of the deletions start or end within repetitive sequence 
elements (Alu or LINES). 
Principal δβ–thalassemia and dHPFH are summarized in the Table IV, while 
the summary Table V shows the hematological results and Hb analysis on the 
deletion conditions listed in Table IV. 
 
It is very difficult to clarify the mechanism by which the deletions alter the 
expression of HbF. Several explanations have been proposed: 
 
 Loss of Regulatory Regions: a regulatory region responsible for repressing 
γ gene expression in adult life lie between the Aγ– and δ–globin. Its loss due to a 
deletion may cause the incapability to switch off γ genes in favor of adult genes. 
 Newly Apposed Enhancer Sequences: there may be a positive influence of 
the newly apposed enhancer sequences (e.g. 3’HS1) translocated from the 3’ end 
of the cluster to 3’ of Aγ gene, activating the promoter of the Aγ– and also the  
Gγ–gene. Besides, some deletions fuse the remaining γ genes with sequences close 
to an OR gene the cluster is surrounded by (Para. 1.3). This brings positive or 
negative regulatory elements normally associated with OR genes into proximity of 
the β–like globin genes. 
 Competition between 
Gγ Aγ and δ β: gene expression involves interaction 
of the β–LCR with gene promoters; the γ genes may be in competition with the δ 
and β genes for expression during adult life. In normal circumstances, this 
competition would favor the δ and β genes as a result of the chromatin 
conformation or stage–specific trans–acting factors or both. When both the δ and 
β gene promoters are deleted, the γ promoters may be free to interact with the  
β–LCR, resulting in the persistent HbF (Steinberg et al., 2009). 
 
Some of the possible mechanisms and the involved trans–acting factors were 
discovered using a subtractive hybridization (SSH) method that identified differently 
expressed transcripts in reticulocytes from a normal and a dHPFH subject. 
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A recent study by de Andrade et al., 2006 selected both HPFH–2 and Sicilian 
δβ–thalassemia (Fig. 18) and compared their transcriptome to normal samples 
through SSH. 
 
This work found transcripts differentially expressed in both normal and in 
HPFH–2 or Sicilian δβ–thalassemia groups. 
Among these, several chromatin remodeling factors (ARID1B, TSPYL1) and 
transcription factors (ZHX2) were found and analyzed: 
ARID1B
2
 (also known as BAF250b) was found increased in the subjects 
heterozygous for HPFH–2 (approximately a 5 and 2 fold change); also TSPYL (a 
member of Nucleosome Assembly Protein family involved in chromatin remodeling) 
was found increased. 
The increased expression of ARID1B and TSPYL1 could maintain an open 
chromatin structure in the region comprising the fetal globin, leading to high levels 
of expression in the adult stage. However, their expression in Sicilian δβ–thalassemia 
is decreased approximately 0.15 fold, which may be a consequence of the fragments 
that are removed in HPFH–2 and maintained in Sicilian thalassemia, such as the 
PYR region, for example. 
                                                 
2  ARID1B is an SWI–like protein, involved in ATP–dependent chromatin modification, and is 
potentially a subunit of the PYR complex, which associates with a γ–δ intergenic region in the β–like 
globin cluster. 
This region has been implicated in γ–globin silencing during the adult stage of development; its 
removal in dHPFH may contribute to the reactivation of fetal globin.  
The PYR complex contains Ikaros as its DNA binding subunit, proteins from the SWI/SNF 
transcription activator chromatin remodeling family and a member of the NuRD transcription 
repressor family, Mi–2. These features suggest that PYR may be an important complex involved in 
globin gene switching. 
Figure 18 
Representation of the human β–globin gene cluster. Black bars represent the extent of the described 
deletions. PYR binding region, 3′ β enhancer and HPFH–2 enhancer are also indicated. 
(de Andrade et al., 2006) 
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ZHX2 has zinc finger and homeobox domains and is categorized as a 
transcriptional repressor. Interestingly, it is located in a genomic region (8q24.13) in 
which a quantitative trait locus (QTL) associated with a heterocellular HPFH was 
recognized (Para. 4.6). 
ZHX2 is downregulated in both HPFH and δβ–thalassemia and its expression 
seems to be inversely correlated to γ–globin in the HPFH samples analyzed. 
 
The presence of transcription and chromatin remodeling factors with altered 
expression in HPFH may indicate that the involvement of trans–acting factors has a 
decisive role in the consequent phenotype. 
A model is proposed by the authors to explain the effect of different deletions 
within the β–globin cluster (Fig. 19).  
Figure 19 
Model to explain the effect of different deletions within the β–globin cluster. 
(de Andrade et al., 2006) 
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Under normal conditions (Fig. 19 A), the β–LCR interacts with the δ– and  
β–globin genes during the adult stage of development, involving intra– and 
interchromosomal interactions mediated by transcription factors and non–coding 
regulatory transcripts, perhaps also involving the PYR complex. 
Various HPFH and δβ–thalassemia deletions may interfere with the expression 
of trans–acting transcription and chromatin remodeling factors in an unknown way, 
leading to a disruption of interchromosomal interactions or decreased expression of 
regulatory non–coding RNAs. 
 
These cis and trans alterations may alter the pattern of β–LCR, promoter, 
enhancer and transcription factor interactions that regulate gene expression in the  
β–globin cluster. 
In addition, different transcription and/or chromatin remodeling factors may 
synergistically interact with the remaining regions in the loci to produce a random 
(δβ–thalassemia) (Fig. 19 B) or stable (HPFH) (Fig. 19 C) patterns of γ–globin 
expression (de Andrade et al., 2006). 
 
4.2 Non–Deletional Hereditary Persistence of Fetal Hb 
(ndHPFH) (HBFQTL1) 
A lot of conditions with persistent HbF are caused by mutations on the γ  
genes promoters; HbF levels in these conditions vary from 3% to 35% with a 
preponderance of either 
Gγ– or Aγ–chains according to the gene promoter containing 
the mutation.  
Analyses of the proteins that bind to the promoters have demonstrated the 
complexity of the region, in which binding sites for different proteins frequently 
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Altered binding of GATA1, OCT1, CP1, CDP1, NF–E3, and the stage selector 
protein SSP have been reported and several mutants have also been studied in 
transient transfection assays or in vitro transcription assays. Several of these 
mutations have been tested in vivo on transgenic mice and recapitulate the human 
phenotype to varying degrees (Steinberg et al., 2009). 
A lot of mutations have been described and are listed at 
http://globin.bx.psu.edu (
Gγ and Aγ entries) named with the position of mutation 
followed by ndHPFH or simply HPFH. Principal entries are summarized in the  
Table VI. 
Individuals with γ promoter mutations have balanced globin chain synthesis 
and a normal MCH (Table VI); on the other hand the mild anemia seen in compound 
heterozygotes for β–thalassemia and the Aγ −196 and −117 mutations may indicate 
that the total γ + β chain output from the HPFH chromosome in these cases is 
slightly less than normal. Therefore it is clear that haploinsufficiency of the β gene is 
not completely compensated by the expression of γ genes. 
Increased γ chain production is matched by a decrease in the expression of the 
β gene in cis to the γ mutation. This reciprocal relationship could be explained by the 
competition between these two genes for β–LCR. Altered binding of transcription 
Figure 20 
Transcription factor binding sites in the promoters of the γ–globin genes; Aγ and Gγ genes are 
identical in this region. The positions of mutations that result in ndHPFH are indicated. 
(Steinberg et al., 2009) 
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factors to the γ gene promoter as a result of the mutation might alter the association 
with the β–LCR, resulting in a more stable binding to γ genes than would normally 
occur in adult red cells. 
 
Decreased binding of a repressor protein or increased binding of an activator to 
the γ gene promoter could therefore increase the gene’s competitiveness. Different 
mutants would result in different probabilities of an interaction with the β–LCR: this 
could explain also the variability in the amount of HbF produced (Steinberg et al., 
2009). 
Some ndHPFH will be discussed individually. 
 
4.2.1 
Aγ −117 G→A (rs35378915) 
It was first found in a Greek HPFH allele; it is also referred as the Black or 
Greek ndHPFH. It has been found linked to haplotype VII in Greeks and Italians 
(Pistidda et al., 1995). Heterozygotes produce 14.2 ± 1.1 g/dl of Hb, with normal 
RBC indices and HbA2. This mutation rise HbF up to 12.1 ± 2.8 % on total Hb, with 
the prevalence of 
Aγ globin (93.4 ± 4.7 % of HbF) (Table VI). α/non–α ratio  
nearly close to 1 indicates that this mutation does not shift the balance between α and  
γ + β + δ globins (Steinberg et al., 2009).  
Aγ −117 G→A locates between the two distal CCAAT elements (2 bases 
upstream the distal CCAAT box of HBG1) and results in increased CP–1 (NF–Y) 
(2–3 fold) and CDP binding (3 fold), while interfering with the binding of an 
erythroid cell specific factor, NF–E3 (Superti–Furga et al., 1988) and GATA1 (Berry 
et al., 1992). 
Also the DR–1 binding site is disrupted by the HPFH −117 mutation reducing 
its γ–gene silencing function (Para. 2.1) (Steinberg et al., 2009). 
 
Two mechanisms have been proposed to explain the HPFH phenotype: the  
Aγ −117 HPFH mutation either increases the transcription by increasing promoter 
strength or it allows γ gene expression in the adult by interfering with γ gene 
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silencing. At least in the system used in vivo on mice transfected with a silenced 
construct containing the –117 HPFH mutation, the most likely mechanism of action 
of this HPFH is the increase in γ gene promoter strength (Li et al., 2001).  
Through transient expression assay it has been defined that Greek HPFH allele 
produces about 1.4 times as much RNA as the wild type 
Aγ gene when standardized 
against RNA transcribed from the 
Gγ genes in cis (Rixon and Gelinas, 1988). 
It is of interest that the activity of the δ–globin gene is consistently decreased 
in all types of HPFH: it can reach up to 70% decrease in homozygous Sardinian  
–117 HPFH patients (Ottolenghi et al., 1989). 
 
4.2.2 
Aγ −196 C→T (rs35983258) 
It is usually referred as Italian ndHPFH; this mutation has been found in 
unrelated persons with the same phenotype and occurs mostly in Italy; this ndHPFH 
apparently arose independently since it is associated with different haplotypes 
(OMIM entry: 142200.0027). 
It is associated with higher levels of HbF (13.7 ± 2.9 %), mostly α2
Aγ2, and 
normal levels of HbA2 (Table VI). 
It is possible that this mutation alters the affinity of a transacting factor. It is 
surrounded by a GATA1 and Sp1 binding site. 
In Sardinia, the 
Aγ −196 C→T ndHPFH mutation can be found associated with 
the β0(39) CAG→TAG stop codon of the HBB gene: this association is named 
Sardinian δβ–thalassemia due to the presence of a β–thalassemia allele and the 
reduced amount of δ globin (HbA2), which would be expected at higher levels in a  
β–thalassemia trait. It is supposed that the reason why HBD gene is under–expressed, 
although the δ gene is entirely normal, is probably due to the suppressive effect of 
the cis ndHPFH mutation, which may compete for the transcription factors and  
β–LCR (Loudianos et al., 1992). 
This two closely linked mutations are expected to give selective advantage 
because the β0(39) mutation protects against malaria (Ayi et al., 2004) while the 
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increased γ–globin production ameliorates the severity of the β–thalassemia (Taher et 
al., 2009). 
 
Two mutations close to 
Aγ –196 have been studied in vivo: the British  
Aγ –198 T→C and the Brasilian Aγ –195 C→G. The two mutations are described 
below to show how two very adjacent mutations can act oppositely. It is unclear 
whether the 
Aγ –196 acts similar to –198 or –195. However the –196 mutation is 
associated with high levels of HbF (15–20%), expressed in a pancellular fashion, 
whereas the –198 and –195 mutations are associated with lower levels of HbF  
(3–10%) expressed in a heterocellular fashion (Forget, 1998). 
 
Aγ –198 T→C creates a motif that can play a role similar to that of the 
γCACCC box, increases Sp1 binding and creates novel binding for another 
ubiquitous protein. The –198 HPFH mutation increases γ gene expression by 4 to 5 
fold in stable or transient transfections of erythroid cell lines, while this enhancement 
is not observed in non–erythroid cell lines. The results of in vivo studies indicate that 
the –198 T→C HPFH mutation up–regulates γ gene transcription only in presence of 
a γCACCC box deleted construct, while the level of γ mRNA is similar to the 
controls when the mice are transfected with a non–deleted construct. 
The same mechanism may account for the HPFH phenotype in humans: 
normally, in the adult, the CACCC box may become inactivated, contributing to the 
down–regulation of γ gene expression, but the –198 T→C mutation produces an 
alternative CACCC box that allows the interaction of the γ promoter with the LCR, 
resulting in the phenotype of HPFH (Li et al., 2001). 
 
On the contrary, the Brasilian 
Aγ –195 C→G HPFH does not create a CACCC 
motif, but decreases the affinity at the Sp1 protein. In an in vitro study it was shown 
that this ndHPFH cause upregulation of the luciferase activity in erythroid cells and 
that the presence of HS2 is necessary for the increase in the expression of the vector, 
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for effective promoter action. However the enhancement produced in vitro is several 
times less than that seen in vivo (Takahashi et al., 2003). 
 
4.2.3 
Gγ −175 T→C (rs63750654) 
This mutation has been found in Black, Sardinian and British persons. Data 
show a slightly reduced Hb (12.7 ± 1.1 g/dl) and normal RBC indices. HbF levels are 
among the highest for 
Gγ ndHPFH (20.3 ± 2.8%), mostly α2
Gγ2 (Table VI) (Steinberg 
et al., 2009). 
The region where the –175 mutation is located in is noteworthy because it 
contains an octanucleotide sequence that is present in the promoter region of a 
number of genes and is the binding site for the trans–acting factor OCT1; in addition 
this octamer is flanked on either side by a consensus sequence for GATA1. 
The −175 HPFH mutation affects the one nucleotide that is present in the 
partially overlapping binding sites of both factors (Forget, 1998), altering the 
interaction with GATA1 and removing the binding site for OCT1. However, the 
relevance of these in vitro effects to the HPFH phenotype remains unknown 
(Steinberg et al., 2009). In transient and stable transfection assays, the –175 HPFH 
mutation augments the strength of the γ promoter ∼4 fold. The –175 HPFH mutation 
also decreases binding of HMG1, a ubiquitous chromatin structural protein, but the 
physiological meaning of this decline is unclear (Li et al., 2001). 
 
4.2.4 
Gγ −158 C→T (rs7482144) 
Within the β–cluster there are numerous polymorphisms affecting HbF 
production in many different ways. The best known of these is the 
Gγ −158 C→T, 
which creates an Xmn I restriction site. This variant, formerly grouped as ndHPFH, 
have now to be reclassified based on the new findings. 
Normal individuals who are homozygous for T (Xmn I +/+) may have a slight 
increase in F cells, and it has been associated with increased HbF production under 
conditions of erythropoietic stress. In fact, among SCD, HbE and β–thalassemia 
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patients, those with −158 T tend to have higher HbF levels and a higher proportion of 
Gγ chains. 
The cause of this differences in phenotype is unknown as no transcription 
factors seems to bind there, but it may be related to the different chromosomal 
backgrounds and mutations on other genes involved in Hb switch which are in 
linkage disequilibrium with this SNP (Steinberg et al., 2009). 
To understand whether Xmn I SNP is a causal variant at the β–globin locus or 
not, the association between Xmn I SNP and HbF levels was replicated through 
GWAS in African–Americans with SCD. 
However, rs10128556 (the Hinc II G→A (–/+) polymorphism on HBPB1) was found 
more strongly associated with HbF levels than Xmn I by two orders of magnitude. 
So, when conditioned on Hinc II SNP, the HbF association result for rs7482144 is 
not significant, indicating that Xmn I is not a causal variant for HbF levels in the 
population analyzed (Galarneau et al., 2010). 
 
4.3 Modern approaches for the identification of genetic 
modifiers of β–thalassemia phenotype 
Elucidation of the just described cis–acting genetic modifiers has not been too 
difficult as these loci have a major clinical effect and the genetic variants are 
common; however, these modifiers do not explain all the clinical heterogeneity and 
many important questions remain regarding the role of other genetic modifiers and 
their interactions with the β–globin gene cluster. 
Due to the complex interaction of the multiple factors, a genetic approach 
might be the most efficacious way of dissecting the molecular mechanism and 
identifying the modifier genes. 
The modern approach involves association studies, which looks for differences 
in the frequencies of genetic variants between ethnically matched cases and controls 
to find variants that are strongly associated with the disease or trait (in this case, HbF 
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Until recently, association studies have been based on candidate genes selected 
according to researchers understanding of the disease pathophysiology; however 
guessing the causal genes could well leave out some of the key genetic players. 
In contrast, genome wide association studies (GWAS) scans the whole 
human genome and is able to reveal the unsuspected interactions. It is generally 
accepted that any two genomes are 99.9% identical and GWAS looks for differences 
between different genomes to identify the variants that are more common in the 
cases when compared to case controls. 
The genome is thus portrayed as a series of high linkage disequilibrium (LD) 
regions named haplotype blocks, separated by short segments of very low LD 
referred to as recombination hotspots. 
Nevertheless GWAS may tell if a locus is important in the pathogenesis of a 
condition but it does not identify the causal variants and the mechanism that is 
responsible (Thein, 2008). 
 
4.4 HBFQTL2: Chromosome 6–linked  
(HMIP 6q22.3–q23.1) (OMIM #142470) 
One of the first reports of HPFH unlinked to the β–globin gene cluster was 
done by Thein et al., 1994: she reported a large Indian family with β–thalassemia 
and/or HPFH in which HbF segregated as an independent trait from β–thalassemia. 
The locus linked to the HbF production was found two years later and mapped on 
chromosome 6q22.3–q23.1 (Craig et al., 1996), which was further refined to a  
1.5–Mb region containing five coding genes (AH11, MYB, ALDH8, HBS1L, and 
PDE7B) and four non–coding RNAs (Close et al., 2004; Steinberg et al., 2009). 
A systematic investigation of genetic variants between HBS1L–MYB was then 
made by resequencing this 125–kb region by using DNA from 32 European control 
subjects. It identified the principal genetic variants that account for the chromosome 
6q QTL for HbF. These variants are located in HBS1L–MYB intergenic 
polymorphism (HMIP) block (Thein et al., 2007). 
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GWAS and sequence analysis of this region allowed for the identification of 
many SNPs correlated with HbF production: rs9376092, rs9399137 (Nuinoon et al., 
2010), rs4895441 (Lettre et al., 2008), rs9389268 (Galanello et al., 2009), and so on. 
  
A recent study provides the functional link between genetic association of 
HMIP with control of fetal Hb and other hematologic parameters. It was suggested 
that HMIP contains regulatory sequences that could be important in hematopoiesis 
by controlling MYB expression: in fact a study identified several potential  
cis–regulatory elements as strong GATA1 signals that coincided with the DNase I 
hypersensitive sites present in MYB–expressing erythroid cells. Therefore, this study 
provides the functional link between genetic association of HMIP with control of 
fetal Hb and other hematologic parameters (Wahlberg et al., 2009). 
These information were confirmed by another study in which it is shown that 
MYB gene is causally involved in controlling HbF production at the HBFQTL2 
locus (Galarneau et al., 2010) 
 
4.5 HBFQTL3: Chromosome X–linked  
(Xp22.2) (OMIM #305435) 
Analysis of HbF levels in healthy Japanese adults led to the suggestion that an 
X–linked gene was involved in increasing HbF levels with a frequency of 11% of 
males affected and 21% of females being carriers. Further studies confirmed a 
linkage between F cell production locus (mapped at Xp22.2–22.3) and HbF 
production (Steinberg et al., 2009), mediated through a not yet defined trans–acting 
mechanism. 
 
4.6 HBFQTL4: Chromosome 8–linked  
(8q) (OMIM #606789) 
In the same large Indian kindred in which it was mapped a gene modifying 
HbF production to chromosome 6q23 (Craig et al., 1996; Thein et al., 1994), it was 
identified another quantitative trait locus (QTL) on 8q conditional on the 
Gγ Xmn I 
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polymorphism. The results indicated that an interaction between the 
Gγ Xmn I site 
and a QTL on 8q influence the production of fetal Hb (Garner et al., 2002). 
 
4.7 HBFQTL5: Chromosome 2–linked and Role of BCL11A 
(2p5) (OMIM #142335) 
GWAS mapping of individuals with HbF made it possible to find a quantitative 
trait locus influencing F cell production on chromosome 2. It maps to a zinc–finger 
protein, BCL11A, previously implicated in leukemias (Steinberg et al., 2009). The 
strongest association was with the SNP rs11886868 (C allele) in intron 2 of the 
BCL11A gene. The C allele was also associated with an ameliorated phenotype in 
patients with β–thalassemia and SCA: this may indicate that this SNP may modify 
these phenotypes by increasing HbF levels (Galanello et al., 2009; Uda et al., 2008). 
Other SNPs associated with HbF were detected: rs766432 (Nuinoon et al., 
2010), rs4671393, rs7557939 (Lettre et al., 2008). 
The variants characteristic of higher levels of HbF are associated with lower 
levels of BCL11A mRNA expression. This 
variation in expression appears to have an 
effect on the function of BCL11A at the 
human β–globin locus, where it is thought to 
act with the erythroid transcription factors 
GATA1 and FOG1, as well as the NuRD 
remodeling and repressor complex to silence 
the γ–globin genes (Fig. 21) (Sankaran et al., 
2010). 
 
Chromatin immunoprecipitation (ChIP) experiments showed that BCL11A 
directly binds to several locations of the β–globin locus in adult erythroid progenitor 
cells; one of these is the GGCCGG motif at position −56 to −51 of the Gγ gene 
promoter (Steinberg et al., 2009). 
 
Figure 21 
BCL11A role on the human β–globin locus. 
(Sankaran et al., 2010) 
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Some interacting partners of BCL11A have been already discovered: the 
lysine–specific demethylase 1 and repressor element–1 silencing transcription  
factor corepressor 1 (LSD1/CoREST) histone demethylase complex interacts with 
BCL11A and is required for full developmental silencing of mouse embryonic β–like 
globin genes and human γ–globin genes in adult erythroid cells in vivo. 
Furthermore, the DNA methyltransferase 1 (DNMT1) is identified as a 
BCL11A–associated protein in the proteomic screen and it is required to maintain 
HbF silencing in primary human adult erythroid cells (Xu et al., 2013). 
 
4.8 HBFQTL6: Chromosome 19–linked and Role of KLF1 
(19p13.2) (OMIM #613566) 
HPFH was found in 10 of 27 members from a Maltese family in which HbF 
(α2
Gγ2 and α2
Aγ2) ranged from 3.3 to 19.5% of total Hb, displaying mild hypochromic 
microcytic indices displayed by the HPFH individuals. Through a genome–wide 
SNP scan followed by linkage analysis a candidate region on chromosome 
19p13.12–13 was found. Sequencing revealed a nonsense mutation in the KLF1 
gene, which ablated the DNA–binding domain of this key erythroid transcriptional 
regulator. Deregulation of KLF1 could explain the altered erythroid indices.  
Expression profiling on primary erythroid progenitors showed that KLF1 target 
genes were downregulated in samples from individuals with HPFH. Functional 
assays suggested that, in addition to its established role in regulating adult globin 
expression, KLF1 is a key activator of the BCL11A gene, which encodes a 
suppressor of HbF expression (Borg et al., 2010). 
The new studies link HPFH, KLF1 and BCL11A together in a unified model. 
In fact KLF1 indirectly regulates γ–globin expression by directly regulating BCL11A 
and globin switching. During embryonic and fetal development or in KLF1 
haploinsufficient adults, KLF1 levels are low, resulting in low levels of adult  
β–globin and BCL11A and high levels of γ–globin. 
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In adults with two functional copies of KLF1, increased expression of KLF1 in 
definitive red blood cells promotes high levels of β–globin and BCL11A expression, 
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AIM OF THIS STUDY 
 
β–thalassemia affects millions of individuals worldwide. These Hb disorders 
are characterized by extreme clinical heterogeneity, complicating patient 
management and treatment. A better understanding of this clinical variability would 
dramatically improve care and might also guide the development of novel therapies 
(Lettre, 2012). 
HbF has been shown as a common and major modifier of disease severity in 
individuals with β–thalassemia. γ–globins in fact reduce the relative excess of  
α–globin and provide a potent selective survival advantage for cells making HbF in 
the context of the ineffective erythropoiesis characteristic of the most severe forms of 
β–thalassemia. 
Certain β–globin promoter mutations (e.g. β+(−87)) are associated with 
increased γ–chain synthesis from the same chromosome; also coinheritance of an 
HPFH gene is associated with higher HbF and gives advantage in presence of  
β–thalassemia. In addition to SNPs within the β–globin locus, genome–wide 
association studies (GWAS) have identified additional loci that can contribute 
significantly to the variation in HbF levels (Nienhuis and Nathan, 2012). 
 
In the Sardinian population, the incidence of β–thalassemia trait is very high 
(approximately 12.5%); among these, 95% carry the β0(39) nonsense mutation and 
about 2% the β0(–A)6 frameshift mutation (Masala et al., 1988; Rosatelli et al., 
1987; Rosatelli et al., 1992). In the Sardinian population β0(39) mutation was found 
associated with five different Orkin haplotypes: II (64%), I (22%) and IX (4%) are 
the most common (Masala et al., 1988; Piras et al., 2005; Pirastu et al., 1987). 
In Sardinia, homozygous β0(–A)6 or compound heterozygous β0(–A)6/β0(39) 
show TI forms more frequently than TM. 
In homozygous β0(39)–thalassemia TM is the most frequent phenotype, 
although rare TI can be found (10%) (Galanello et al., 1989). 
HbF, when present, is the only useful Hb tetramer synthesized and this is 
mostly the principal cause of the intermediate phenotype. 
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This research intends to increase knowledge about the regulation of γ–globin 
genes, with particular attention to the switch fetus→adult. 
It may give support to the current pre– and post–natal diagnosis and 
therapeutic approach of β–thalassemia in order to prevent unnecessary and harmful 
transfusion regimes. 
 
The molecular mechanisms undergoing the fetus→adult switch were 
investigated in healthy individuals showing persistence of HbF, both in the presence 
and absence of β–thalassemia trait. In fact, these individuals are an excellent natural 
model for the study of the mechanisms that lead to a failure in the fetal genes 
switching off. 
 
Samples were analyzed to: define the qualitative and quantitative composition 
of the Hb; identify potential β–thalassemia mutations, distinguish ndHPFH from 
dHPFH; study SNPs and microsatellite within the β–gene or the entire cluster and 
possibly relate the persistence of HbF with the presence of specific polymorphic 
configurations. 
ndHPFH promoters were also evaluated in in vitro reporter assays to quantify 




 ................................................................................................................ MATERIALS AND METHODS 
Sandro Trova 
Analysis of genetic determinants associated with Persistent Synthesis of Fetal Hemoglobin 
PhD Thesis in Biomolecular and Biotechnological Sciences (Biochemistry and Molecular Biology) 
 Università degli Studi di Sassari 
60 
MATERIALS AND METHODS 
 
5. CHOICE OF THE SAMPLES 
Whole–blood samples were collected using EDTA as anticoagulant at the 
Blood Transfusion Centre of ASL N. 2 of Olbia. 
All subjects have released informed consent. 
The samples were selected on the basis of the results obtained by means of 
CE–HPLC and hematological data collected by the Blood Transfusion Centre of 
Olbia. 
Only samples with HbF levels above 5% were included in this research, in 
order to keep out heterocellular HPFH (hHPFH) (Chap. 4). 
 
6. PREPARATION OF THE SAMPLES 
One aliquot of the whole blood (Para. 6.1) was used for biochemical analysis 
(Chap. 7), the other one (Para. 6.2) for DNA extraction and consequent molecular 
analysis (Chap. 8). 
 
6.1 Preparation of Hemolysates 
The first blood aliquot was washed through centrifugation at 1300 g for 5’ in 
physiological solution (NaCl 0.9%) until the supernatant appeared clean and clear. 
The addition of one volume of ipotonic solution (tridistilled H2O, mQ) causes the 
hemolysis and the consequent suspension of Hb (hemolysate), directly used for 
electrophoretic analysis. 
Chromatography required an additional step to remove cell membranes: half of 
the volume of CCl4 was added to the solution. After centrifugation (20900 g for 2’), 
the supernatant was recollected and contained Hb in water could be readily used for 
HPLC analysis or stored at –20°C for a long time. 
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6.2 DNA extraction and quantification 
DNA extraction was performed either with commercial kits (GenElute™ 
Blood Genomic DNA Kit, Sigma) or Salting out (Miller et al., 1988). The salting out 
protocol, based on Miller et al., 1998, can be found at the end of this Thesis 
(Protocol 1). 
DNA was quantified with NanoDrop 8000 Spectrophotometer (Thermo 
Scientific). 
 
7. BIOCHEMICAL ANALYSIS OF THE SAMPLES 
At the biochemical level, unambiguous Hb phenotype determination requires 
the combination of electrophoretic and chromatographic techniques: cation exchange 
high performance liquid chromatography (CE–HPLC) and isoelectric focusing 
(IEF) were used to separate Hb tetramers, while denaturing polyacrylamide gel 
electrophoresis (AUT–PAGE) and Reverse Phase–HPLC (RP–HPLC) made it 
possible to distinguish the constituent globin chains. 
Because of its powerful resolution, IEF can resolve proteins that differ in pI by 
as little as 0.01. Globin chains with a neutral–to–neutral amino acid substitution can 
be separated by AUT–PAGE and, especially, RP–HPLC. 
 
7.1 CE–HPLC 
Cation–Exchange High Performance Liquid Chromatography (CE–HPLC) was 
performed by the staff of Blood Transfusion Centre of Olbia on the Bio–Rad Variant 
automated analyzer with the “β–thalassemia short” program. 
It has been designed to separate and determine in 5–6 min the area percentages 
for HbA2 and HbF and to provide qualitative and quantitative determinations of 
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7.2 IEF 
Isoelectric focusing was performed on a polyacrylamide slab gel  
(%T:%C = 5.2%:3%) where a pH gradient is formed through ampholytes; proteins 
move until the position in the gel at which the pH is equal to the pI is reached and 
there “focus”. 
The gel was prepared in a sandwich of treated glass: the mold was brushed 
with a “Repel solution” (5% dimethyldichlorosilane, in chloroform); the support 
instead was treated with a “Bind solution” (0.2% Silane A174 in acetone). 
The mixture for the gel was prepared by adding ampholytes at pH 6.7 to 7.7 
(6.2%), ampholytes at pH 3–10 (0.5%), TEMED (0.15%) and ammonium persulfate 
(APS, 0.56 mg/ml), and it was casted into the prepared sandwich for 1 h at room 
temperature. 
At this point a pre–run was necessary to form the pH gradient: strips of 
absorbent paper were wetted with the specific electrolyte (40 mM glutamic acid for 
anode, 0.1 M NaOH for cathode) and placed onto the gel. A voltage of 400 V at 4°C 
was applied to the gel until the amperage went below 4 mA. 
20 µg of Hb were loaded and run for 2 h at 1600 V at 4°C. 
At the end of the run, the Hbs were fixed in Tricloracetic Acid (20% TCA) for 
10’; the gel was then colored for 30’ in a “colorant solution” (0.1% BBF, 50% EtOH, 
5% Acetic Acid) and decolored in the same solvents (30% EtOH, 6% Acetic Acid) 
(Masala and Manca, 1991). 
Yellow colored bands were turned into blue by soaking the gel into water: this 
allowed a semi–quantitative densitometric analysis at 600 nm. 
 
7.3 Preparative IEF: HbF enrichment 
In adults, HbF concentrations are sometimes too low for the quantification of 
Gγ/Aγ ratio by means of RP–HPLC. It is therefore necessary to perform a preliminary 
step to enrich the sample in HbF. 
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Minimum 4 μg of HbF need to be injected in RP–HPLC to be detectable. To be 
sure to recover a sufficient quantity of HbF, at least 30 μg of HbF were loaded on 
IEF gel. 
45 μl of concentrated hemolysate (depending on the concentration of %HbF 
obtained by CE–HPLC) were placed on a strip of absorbent paper (30x5 mm) lying 
on the focusing gel. 
After the run the HbF band was excided from the gel and suspended in 200 μl 
circa of mQ. 
Subsequent cycles of freezing and thawing allowed all the HbF to pass from 
gel to water; centrifugation at top speed for 30’ and filtration of the supernatant 




Polyacrylamide Gel Electrophoresis in presence of Acetic Acid, Urea and the 
non–ionic detergent Triton X–100 (AUT–PAGE) separates denatured globin chains 
by their net positive charge and hydrophobicity. 
The polyacrylamide gel (%T:%C = 12%:0.6%) mixture was composed of 6M 
Urea, 4.5% Acetic Acid, 1.8% Triton X–100, 0.36% TEMED, 0.4 mg/ml Riboflavin. 
The gel (160x200x0.75 mm) was casted under UV for 1h. 
Each sample was denatured in a “denaturing solution” (8M Urea, 10% Acetic 
Acid, 10% β–mercaptoethanol) for at least 30’ at room temperature and 15 μg of 
denatured sample were loaded into the well. The tracking dye (pyronin–G) was 
added to the denaturing solution to follow the run. 
The run was done on PROTEAN II xi Cell (Bio–Rad) in 5% Acetic Acid, for 
19 hours at 4°C, with constant amperage (6 mA for one slab, 10 mA for two). 
After the run, the gel was colored and fixed with a “colorant solution” (0.5% 
Coomassie Brilliant Blue R–250, in 30% methanol and 7% Acetic Acid) and 
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7.5 RP–HPLC 
Reversed Phase–High Performance Liquid Chromatography (RP–HPLC) was 
performed on a 10°C thermostated Vydac C4 column (4.6x250 mm, ⌀ 300 Å) with a 
linear gradient of acetonitrile:water; the more the proteins are hydrophobic, the more 
they are retained by the column. 
The mobile phase was composed of two buffers: A) 20% acetonitrile CH3CN, 
0.1% trifluoroacetic acid TFA; B) 60% CH3CN, 0.1 TFA (Masala and Manca, 1994). 
Hemolysates, deprived of cell membranes (Para. 6.1) were diluted to 0.1% Hb 
with mQ and 20 μl were injected into the column. 
The run conditions were adjusted according to the needs, in terms of linear 
gradient of %B and time ( ) and flow (1 to 1.2 ml/min). 
By means of RP–HPLC, relative concentrations of β–globins respect to the 
non–α globins and the Gγ/Aγ ratio were calculated. 
 
8. MOLECULAR ANALYSIS OF THE SAMPLES 
Through the information obtained from electrophoresis and chromatography, 
direct DNA sequencing of specific PCR products was performed in order to identify 
the abnormality involved, which may consist in single point mutations or 
microinsertions/deletions. The search for large deletions (e.g. dHPFH) is facilitated 
by the GAP–PCR and multiplex ligation–dependent probe amplification (MLPA). 
 
8.1 PCR 
Polymerase Chain Reaction (PCR) was used to amplify DNA fragments for 
sequence reaction. 
Except for some oligonucleotide primers already published, the others were 
designed using the online software Web Primer (http://www.yeastgenome.org/cgi–
bin/web–primer) (See Table VII). All the position, when not explicit, are referred to 
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Each reaction was performed with Termus aquaticus (Taq) DNA Polymerase 
(Sigma) for the subsequent sequence analysis or Pyrococcus furiosus (Pfu) 
Polymerase (Life Technologies) for cloning. 
Reactions were carried out on a Thermal Cycler (Gene Amp PCR System 2700 
and 2400, Applied BioSystem). All reactions were commenced by a Hot Start. 
 
To improve throughput and specificity, Betaine 1 M (Sigma) was sometimes 
added to the reaction. Betaine acts as a PCR enhancer by reducing the formation of 
secondary structure caused by GC–rich regions (Henke et al., 1997) and eliminating 
the base pair composition dependence of DNA melting (Rees et al., 1993). 
 
Complete 
Gγ and Aγ gene 
Complete 
Gγ and Aγ genes were amplified with the same Chemical and 
Thermal protocol, except for the primer pairs. 
- R160–Gγ2 primers for Gγ gene 
- R159–Aγ10 primers for Aγ gene 
Chemical protocol: 1X Buffer, 2 mM MgCl2, 375 μM dNTPs, 0.3 μM of each 
primer, 1M Betaine, 0.2 μg of genomic DNA, 2.5 U of polymerase. 
Thermal file: 3’ at 95°C, 35 cycles of 1’ at 95°C, 1’ at 52°C and 3’ at 72°C. 
 
Eminested and nested PCR for γ genes: 
The larger and low–throughput fragments obtained by amplification of 
complete γ genes (See Above) were used for eminested and nested PCR to increase 
the quantity of DNA for sequence analyses. 
Chemical Protocols and Thermal files were optimized to be identical for all the 
fragments, except for the primer pairs: 
Chemical Protocol: 1X Buffer, 2 mM MgCl2, 250 μM dNTPs, 0.3 μM of each 
primer, 0.3 μg of genomic DNA, 2.5 U of polymerase. 
Thermal file: 3’ at 95°C; 35 cycles of 1’ at 95°C, 45’’ at 50°C and 3’ at 72°C; 
additional final extension was added (4’ at 74°C). 
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Gγ gene eminested from Gγ R160–Gγ2 fragment: 
- R160–R161 primers amplify Gγ promoter (from –623 to +53, in 5’UTR) and 
were used to identify 
Gγ–ndHPFH mutations. Through this fragment the Gγ 
−158 C→T (Xmn I polymorphism) was also determined. 
- Gγ1–Gγ2 primers amplify 780 bp (from +945 in IVS2 to +1726 in 3’UTR). 
This fragment was used to define the Hind II SNP of Orkin haplotype with 
sequencing primer AGγ8. 
 
Aγ gene eminested from Aγ R159–Aγ10 fragment 
- R159–R161 primer pair amplifies Aγ promoter (from –622 to +53, in 5’UTR) 
and was used to identify 
Aγ–ndHPFH mutations. 
- Gγ1–Aγ10 primers amplify 989 bp (from +941 in IVS2 to +1929 in 3’UTR). 
This fragment is also used to define the Hind II SNP of Orkin haplotype with 
sequencing primer AGγ8. 
 
Complete β gene 
The complete β gene was directly amplified from genomic DNA with 3 
different PCRs, each with its own Chemical and Thermal protocol. 
 
- P1–P2 primers amplify a 706 bp region (–140 to +566), encompassing a region 
from the proximal promoter to the beginning of IVS2. 
Chemical Protocol: 1X Buffer, 3.5 mM MgCl2, 250 μM dNTPs, 0.3 μM of 
each primer, 0.3 μg of genomic DNA, 2.5 U of polymerase. 
Thermal file: 3’ at 95°C; 35 cycles of 1’ at 95°C, 45’’ at 65°C and 1’ at 72°C; 
additional final extension was added (4’ at 74°C). 
- β7–β8 primers amplify a 923 bp region (+333 to +1255), including part of exon 
2 and IVS2. This fragment contains also the Ava II polymorphism for Orkin 
haplotypes. 
Chemical Protocol: 1X Buffer, 3 mM MgCl2, 250 μM dNTPs, 0.3 μM of each 
primer, 0.3 μg of genomic DNA, 2.5 U of polymerase. 
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Thermal file: 3’ at 95°C; 35 cycles of 1’ at 95°C, 1’ at 60°C and 1’ at 72°C; 
additional final extension was added (4’ at 74°C). 
- β9–β10 primers amplify a 956 bp region (+799 to +1764), from IVS2 to 5’UTR 
of β–gene. 
Chemical Protocol: 1X Buffer, 1.5 mM MgCl2, 250 μM dNTPs, 0.3 μM of 
each primer, 0.3 μg of genomic DNA, 2.5 U of polymerase. 
Thermal file: 3’ at 95°C; 35 cycles of 1’ at 95°C, 1’ at 55°C and 1’ at 72°C; 
additional final extension was added (4’ at 74°C). 
 
SNPs and microsatellites on the β cluster 
To define both Orkin haplotypes (Para. 3.1.2) and De Angioletti configurations 
(Chap. 4), different PCRs were set for each SNP or microsatellite. 
All the PCRs contained 1X Buffer, 250 μM dNTPs, 0.3 μM of each primer, 0.3 
μg of genomic DNA, 2.5 U of polymerase. MgCl2 was used at different 
concentrations (from 1.5 to 4 mM). 
Thermal file was identical for all the PCR except for the annealing temperature 
(Ta): 5’ at 95°C; 35 cycles of 1’ at 95°C, 1’ at Ta and 1’ at 72°C; additional final 
extension was added (4’ at 74°C).  
MgCl2 and annealing temperature can be found below. 
 
- HS2_F–HS2_R [3.5 mM MgCl2, Ta=57°C]: these primers amplify a fragment 
that contains the microsatellite (AT)xNy(AT)z in β–LCR–HS2. 
- 5’ε_F–5’ε_R [2.5 mM MgCl2, Ta=51°C]: this pair isolate a region upstream to 
the ε gene in which a Hinc II restriction (GTCAAC) site is present (rs3834466, 
AA/A +/−). 
- pre_Gγ_F–pre_Gγ_R [2.5 mM MgCl2, Ta=55°C] primers amplify a fragment 
in the distal promoter of 
Gγ gene, containing the polymorphisms at −1450 T/G, 
−1280 G/A and −1225 A/G of the so called pre–Gγ framework. 
- 
Gγ −158 C→T (Xmn I polymorphism), Gγ and Aγ IVS2 microsatellites, Gγ and 
Aγ Hind III: see Para. 8.1, “Eminested and nested PCR for γ genes” 
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- pseudo_β_F–pseudo_β_R [1.5 mM MgCl2, Ta=55°C] primers identify the 
Hinc II restriction site (GTTGAC) on the ψβ1 gene (rs10128556 G/A (−/+)). 
- 3’pseudo_β_F–3’pseudo_β_R [3.5 − 4 mM MgCl2, Ta=55°C] isolate a region 
~2.5 kb downstream the ψβ1 gene in which a Hinc II (GTTAAC) restriction 
site can be present: the polymorphism (T/A −/+) is located at −5003 bp to the 
CAP of δ gene. 
- pro_β_F– pro_β_R [3.5 mM MgCl2, Ta=51°C] primer pair amplifies a portion 
of the distal promoter region of β–globin gene where (AT)xTy motif is present.  
- 3’β_Bam_F–3’β_Bam_R [2.5 mM MgCl2, Ta=51°C] fragment locate 8.2 kb 
circa downstream the β–globin gene, in which a Bam HI restriction site 
(GGATCC) is present (G/A +/−). 
 
8.2 MLPA 
MLPA (Multiplex Ligation–dependent Probe Amplification) is a multiplex 
PCR method detecting abnormal copy numbers of up to 50 different genomic DNA 
or RNA sequences, which is able to distinguish sequences differing in only one 
nucleotide (Schouten et al., 2002). 
MLPA probes hybridize to the target, are legated together to form a ssDNA 
and are amplified by a single PCR primer pair. The resulting amplification produces 
marked fragments from 130 and 480 nt in length and can be analyzed by capillary 
electrophoresis. 
Comparing the peak pattern obtained to that of reference samples indicates 
which sequences show aberrant copy numbers (http://www.mrc–holland.com). 
MLPA P102 HBB probemix (MRC–Holland) was used for copy number 
quantification when a unknown deletion/duplication was suspected on the β–cluster. 
MLPA reaction was performed according to the provided protocol, by using 
100 ng of DNA and a 20 h hybridization step. 
Data were analyzed with the Coffalyser.Net MLPA data analysis software 
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8.3 GAP–PCR 
When the breakpoint sequences are known, GAP–PCR can readily identify 
large deletions. It consist in a multiplex PCR with a common forward primer and two 
different reverse primers or vice versa: one pair flanks the deletion and produces a 
PCR product only when the deletion is present; the other one is used as control and 
amplifies the non–deleted chromosome. 
 
Sicilian δβ–thalassemia was confirmed thanks to the GAP–PCR method using 
F1, F2 and F3 primers. F1–F2 fragment (1585 bp) is produced when a non–deleted 
allele is present; F1–F3 fragment (1150 bp) is only amplified when the Sicilian  
δβ–thalassemia allele is present. 
PCR was performed in a 25 μl reaction volume containing 1X Buffer, 1.5 mM 
MgCl2, 200 μM dNTPs, 10 pmol of each primer, 100 ng of DNA, 0.5 U of Taq 
Polymerase (Sigma). 
Thermal file: 4’ at 94°C; 30 cycles of 1’ at 94°C, 1’ at 60°C and 2’ at 72°C; 
additional final extension was added (4’ at 72°C) (Craig et al., 1994). 
 
8.4 PCR fragment purification and quantification 
After the amplification, all the reaction volume was electrophoresed through a 
1–1.2% agarose, 1X TAE, etidium bromurated gel at 7.5 volts/cm for 45 hour in 
presence of a molecular weight marker (Marker III, VI and 100 bp, Roche). 
Bands were visualized on an UV transilluminator, quantified by comparison 
with the marker and excised with sterile scalpel. 
DNA was recovered from agarose by means of the Montage Gel Extraction Kit 
(Millipore). 
 
8.5 Sequence Reaction 
The sequence reaction was performed by using the BigDye Terminator v3.1 
Cycle Sequencing Kit (Life Technologies). This kit is based on Sanger chain–
terminating method (Sanger et al., 1977) and each terminator or 
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dideoxyribonucleotide (ddNTP) is associated with a specific fluorochrome. Given 
that all 4 ddNTPs have different fluorochrome, the reaction can be performed in a 
single tube. 
The 20 μl reaction volume mixture consisted of: 2 μl of 5X Buffer, 2 μl of Mix, 
3.2 pmol of primer, 1–2 ng of PCR product per 100 bp. 
Sequence primers were almost always the same ones used in PCR; sometimes, 
because of the length of the fragment or other necessities, specific sequence primers 
were designed. 
Thermal file: 1’ at 96°C, 25 cycles of 10’’ at 96°C, 5’’ at 50°C and 4’ at 60°. 
 
Excess of unincorporated dye terminators and other contaminants 
(unincorporated primers, salts, and so on) were completely removed prior to 
capillary electrophoresis through the Sigma Spin Post–Reaction Clean–Up Columns 
(Sigma). 
Purified sample was mixed with 2 volumes of formamide and injected on a 
3130 Genetic Analyzer (Life Technologies) capillary electrophoresis. 
 
8.6 Sequence Analysis 
Sequence analysis was performed with the help of two software: Geospiza 
FinchTV (http://www.geospiza.com) and Another Plasmid Editor or APE 
(http://biologylabs.utah.edu/jorgensen/wayned/ape/). 
FinchTV allowed for the reading and editing sequence files, while APE was 
used to align the obtained sequences with the reference β–globin cluster (AC #: 
U01317). 
 
9. EXPRESSION STUDIES ON γ PROMOTERS 
The strength of each identified ndHPFH promoter was compared to the wild 
type promoter. To do so, both wild type and mutated promoters were cloned into a 
reporter plasmid whose in vitro expression was measured. γ promoter cloning and 
transfection experiments were based on the work by Chen et al., 2008. 
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9.1 Promoter isolation from genomic DNA 
Both 
Gγ and Aγ wild type and ndHPFH promoters were isolated from genomic 
DNA of the samples who carried the ndHPFH mutations. 
To do so a PCR with the Pyrococcus furiosus polymerase (Pfu) was 
performed: it possess the 3’→5’ exonuclease (proofreading) activity which gives a 
much more accurate and high–fidelity synthesis of DNA compared to the Taq 
polymerase. 
 
Primers were designed by adding restriction sites to the 5’ termini of the 
oligonucleotides used for PCR. These primer–specific restriction sites are transferred 
to the termini of the target DNA during amplification and can then be cleaved with 
appropriate restriction enzymes to generate amplified segments of DNA with 
cohesive termini ready to be cloned in a plasmid. 
Moreover primers were designed to create a different restriction site on each 
end of the amplified DNA to obtain a directional cloning of the fragment. 
To provide an adequate toehold for the restriction enzymes a tail of 3 or 4 
Adenosine (A) was added (Sambrook and Russel, 2001). 
Restriction sites for the chosen enzymes were excluded in the amplified 
fragment through in silico digestion with APE. 
 
Amplification of γ promoters 
γ truncated promoters amplification produced a 1431 bp fragment for Gγ 
promoter (–1382 to +49) and a 1429 bp fragment for Aγ (–1380 to +49). 
Gγ and Aγ promoters were amplified with a different forward primer (Gγ_Kpn I 
and Aγ_Kpn I, respectively). Both the forward primers were designed by adding 
three A and the Kpn I restriction site to the specific primer sequence  
(5’–AAA–GGTAC▼C–sequence–3’). A common reverse primer (R161_Xho I) was 
engineered in the same way (5’–AAA–C▼TCGAG–sequence–3’). 
PCR mix contained 1X Pfu Buffer, 2.5 and 3 mM Mg
2+
 for 
Aγ and Gγ, 
respectively, 375 μM dNTPs, 0.3 μM of each primer, 0.3 μg of DNA, 3U of Pfu 
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(Life Technologies) and was performed through a touch down PCR technique  
(3’ at 94°C; 15 cycles of 45’’ at 94°C, 1’ at 65°C and 4’ at 72°; 20 cycles of 45’’ at 
94°C, 45’’ at 63°C, 4’ at 72°C. A final elongation step 10’ at 74°C was added). 
2 μl of PCR product were electrophoresed and quantified on agarose gel, while 
the remaining volume was immediately purified with phenol:chloroform protocol 
(Protocol 2) in order to inactivate the Pfu
3
 and recover a ready to be digested DNA.  
 
9.2 Cloning of PCR fragments 
γ promoters were first cloned in pBluescript II SK (shortly pSK) to use them in 
cotransfection experiments and then transferred in pGL2–Basic plasmid for 
luciferase assays (Para. 9.3). Both plasmids confer ampicillin resistance to the 
transformed bacteria (Fig. 23). 
 
 
Two digestions were necessary to prepare the fragment and the plasmid for the 
ligase reaction. Both the entire quantity of purified PCR product and 3 μg of plasmid 
were digested with 3 U of the restriction enzyme (Kpn I) for 1 h at 37°C, then 
purified with phenol:chloroform precipitation (Protocol 2) and digested again with 
the second enzyme (Xho I). 
                                                 
3
 The Pfu, when in the deficiency of dNTPs, favors the proofreading activity and could digest the ends 
of the amplified fragment which contain the restriction sites. 
Figure 23 
Plasmids used in this thesis: pBluescript (pSK) on the left; pGL2 Basic on the right. 
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The enzyme with the most alkaline pH was chosen for the second digestion in 
order to have a pH at which the alkaline phosphatase works. 
The double digested plasmid was incubated 1 h at 37°C with Calf Intestinal 
Alkaline Phosphatase (CIAP or CIP) simply adding 1 unit of CIAP directly to the 
second digestion tube. CIAP removes phosphate groups from the 5’ end of the vector 
so that it cannot ligate, preventing the recircularization of the linearized vector and 
improving the possibility to transform only with the vector that contains the 
appropriate insert. 
 
Both double digested insert and dephosphorylated vector were electrophoresed 
for 30’ in a 1% agarose TAE gel. Bands were excided with sterile scalpel and DNA 
was purified with Wizard SV Gel and PCR Clean–Up System (Promega). 
 
Purified DNA was now quantified by means of NanoDrop and a ligation was 
set in a 10 μl volume: 25 ng of vector were ligated to the insert with 3 units of T4 
DNA Ligase (vector:insert 1:3) by incubating at 16°C overnight. Also a negative 
ligase control was set, at the same conditions described above except for the absence 
of insert. 
 
CaCl2 competent bacteria (DH5α strand of E. coli, obtained through  
Protocol 3) were transformed with half a volume of ligase reaction (Protocol 4), 
plated on a LB Agar (Sigma) in presence of ampicillin and incubated overnight at 
37°C. Also a negative ligase control was used to transform DH5α, and it produced 
colonies only if the recircularized vector was present. 
Grown monoclonal colonies were inoculated in 2 ml of LB Broth  
(mini–inoculum) in presence of ampicillin and incubated overnight at 37°C, in 
agitation. 
 
1 ml of the mini–inoculum was used to recover circular plasmid DNA with a 
alkaline lysis combined with SDS technique (mini–preparation) (Protocol 5). 
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Exposure of bacterial suspension to a strong anionic detergent at high pH lyses 
the cells and releases plasmid DNA into the supernatant. 
During lysis all the proteins, broken cell walls and denatured chromosomal 
DNA are caught in large complexes coated with SDS. The denatured material is 
removed by centrifugation, while plasmid DNA is recovered from the supernatant. 
Sodium acetate is added and it neutralizes the pH so that the plasmid can 
renature. In fact, although the alkaline solution completely disrupts base pairing, the 
strands of closed circular plasmid DNA are unable to separate from each other 
because they are supercoiled. As long as the intensity and duration of exposure to 
OH
−
 is not too great, the two strands of plasmid DNA renature when the pH is 
returned to neutral (Sambrook and Russel, 2001). 
Given that the plasmid DNA extracted with Protocol 5 is not pure, it could not 
be used for sequence analysis, but only for digestion with restriction enzymes. 
Recovered plasmid DNA was double digested and electrophoresed to confirm 
the positive transformation: 2 bands are expected and their length should be the same 
as vector and insert, respectively. 
 
When the mini–inoculum had been confirmed to be positive, a midi–inoculum 
was performed: 5 μl of mini–inoculum were inoculated in 50 ml of LB Broth 
(Sigma) in presence of ampicillin and incubated overnight at 37°C, in agitation. 
1 ml of midi–inoculum was used for a pure mini–preparation with the 
commercial kit Wizard Plus SV Miniprep DNA Pur System (Promega) and 450 ng of 
insert were sequenced (with the same primers used in PCR and the sequence primer 
“γ_seq”) (Table VII) to confirm that no mutations were inserted during the cloning 
process. 
A midi–preparation was performed on the midi–inoculum with PureLink 
HiPure Plasmid Midiprep Kit (Life Technologies) to recover a large number of 
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9.3 Reporter assay 
Reporter systems are used to measure transcriptional activity, in particular to 
study promoters and enhancers and their interactions with cis– and trans–acting 
elements as well as their responses to environmental changes. 
Firefly luciferase is largely used as a reporter gene: it produces light from 
luciferin in the presence of ATP (Sambrook and Russel, 2001); the luciferase 
activity, measured through a luminometer (Viktor X5, PerkinElmer), is directly 
correlated to the levels of the enzyme and accordingly to promoter strength. 
 
Transient transfection was chosen for the luciferase assay: K562 cells (Lozzio 
and Lozzio, 1975), an erythroleukemic non–adherent cell line largely utilized in 
expression studies of γ–genes, were used. 
K562 were grown and maintained approximately from 1 to 5·10
5
 cells/ml in 
RPMI 1640 GlutaMAX™ medium (Life Technologies), plus 10% fetal bovine 
serum, at 37°C, 5% CO2. 
 
Cationic lipids were used to convey the DNA inside the cells: they create 
artificial membrane vesicles (liposomes) that bind plasmid DNA molecules; these 
complexes adhere to and fuse with the negatively charged cell membrane, bringing 
the DNA within the cell. This process is called lipofection (Sambrook and Russel, 
2001). Every transfection was carried out in triple and twice. 
Transfection was performed with the Lipofectamine LTX reagent (Life 
Technologies) according to the manufacturer’s protocol; briefly 500 ng of total 
plasmid DNA were added to 0.5 μl of Plus in 100 μl of Opti–MEM serum and 
antibiotic free medium (Life Technologies) and incubated for 5’ at room 
temperature; 1.25 μl of LTX was then added. After a 30’ incubation, the mixture was 
added to 1⋅105 cells/500 μl in a 24–well plate and incubated for 36–48 h at 37°C. 
 
Basically the inserted γ promoter upstream the Firefly luciferase gene can drive 
the expression of the enzyme in K562. Mutations on the cloned promoter were tested 
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to understand their ability to increase or decrease luciferase’s expression and hence 
luminescence. 
The Renilla luciferase expression vector pRL–TK (Promega) (Fig. 24) was 
cotransfected with the proband pGL2  
construct (1:20 pRL:pGL2) for normalization of 
transfection efficiency and to provide an 
internal control for lipofection. Also a negative 
control (with no pGL2 construct) and a positive 
control (pGL2–Control Vector, Promega) were 
used in the experiments. 
 
Cells were then lysed and Firefly (from pGL2) and Renilla (from pRL) 
luciferase gene activities were measured using the Dual–Luciferase Reporter Assay 
(Promega) (Fig. 25). 
The luminescence from the Firefly luciferase of each well was normalized to 
the relative luminescence from the Renilla one, in order to obtain comparable values 




pRL–TK used as coreporter. 
Figure 25 
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RESULTS 
First level analysis 
The samples were analyzed as described in Materials and Methods.  
Table VIII shows the hematological data and Hb quantity and quality of the 
studied samples. 
The parameters were normal, except for a few patients (BGy, BGi, OM, PF) 
that had MCH values on the lower limit compared to normal (MCH 22.4 ± 2.0 vs 25 
to 35 pg). Moreover some samples showed a decreased MCV: BL, BGy, BGi, OM 
(females) (72.5 ± 7.1 vs 78 fl) and PF, CI (males) (72.3 ± 13.2 vs 82 fl). Slight 
reductions of [Hb] and increments of RBC are also visible. These data are 
compatible with a β–thalassemic trait (Table VIII). 
CE–HPLC allowed for the quantification HbF and HbA2 tetramers, while 
through RP–HPLC the globins relative percentages were calculated, defining Gγ and 
Aγ relative ratios (Gγ or Aγ / total of γ globins) (Table VIII). Samples with HbF levels 
lower than 15% needed an HbF enrichment by Preparative IEF (Para. 7.3) before 
injection on RP–HPLC, according to the method described by Manca and Masala, 
1990. 
Figure 26 shows illustrative chromatographic patterns: an increase of the HbF 
(Panel B and C) or γ globin fraction (Panel D, E, F) is notable. 
As shown in Table VIII, all 17 samples presented very high levels of HbF 
compared to normal subjects. With the exception of OM (8.6%) and PF (9.5%), the 
values were always higher than 11% of circulating Hb, with peaks of 28% (FVR). 
HbF levels higher than 5% showed that the increase was not caused by the mere 
presence of a β–thalassemic trait or a hHPFH, but rather, by a pHPFH condition. 
Two samples (BGi and OM) showed higher than normal levels of HbA2  
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CE–HPLchromatograms: A) Normal sample; B) High HbF; C) Increased HbF and HbA2 
RP–HPLchromatograms: D) Persistence of Gγ globin; E) Persistence of Aγ globin; F) Persistence of both 
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By means of chromatographic and electrophoretic techniques (AUT–PAGE, 
IEF) some samples were excluded from this research, when they presented extra–
bands attributable to qualitative variants of hemoglobin. 











IEF and AUT–PAGE confirmed the presence of HbF (Fig. 27 A and B). In 
only 2 subjects the HbF was solely composed by 
Gγ globin (CA and FVR); 7 
presented only 
Aγ (CI, GM, CMA, BA, BGy, CR, CV); some other samples showed 
both globins (Table VIII). 
It is noteworthy that none of these samples showed HbF–Sardinia tetramer (by 
IEF) or 
AγT globin (by RP–HPLC), although this is the most common variant of HbF 
(30% of Sardinian population) (Manca and Masala, 2008). 
No sample showed quantifiable level of HbH (β4). 
 
Second level analysis  
Samples were then analyzed at molecular level: first of all, when possible, the 
complete β–globin gene sequence was obtained. It revealed heterozygous  
β–thalassemic alleles in 7 samples: 6 were β0(39)/β, 1 was β+(–87)/β (Table IX). 
Additionally, β–globin gene sequences revealed five SNPs: the synonymous 
mutation C→T at codon 2 (His→His), and four SNPs in IVS2 (+16 C→G or Ava II 
− → +), +74 G→T, +81 C→T and +666 T→C). These SNPs indicate the existence 
of three β–globin gene frameworks: Type 1 (CCGCT), Type 2 (CCTCT), Type 3 
Figure 27 
A) Isoelectric focusing (1: Heterozygous HbF–Sardinia newborn, 2: HPFH adult; 3: normal adult) 
B) AUT–PAGE: (1: normal newborn; 2: Aγ–HPFH; 3, 4, 5: Gγ+Aγ–HPFH) 
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(TGTTC) (Orkin et al., 1982). Type 1 was found in 11/26, Type 2 in 5/26 and  
Type 3 in 9/26 alleles. Only one case revealed a recombinant β–gene Type  
(GM: CCTTT). 
Promoters of fetal genes were sequenced to identify ndHPFH mutations. The 
choice of amplifying either 
Gγ or Aγ or both globin genes loci was driven by the 
quality of fetal globin expressed by each sample. 
Four ndHPFH were found: 
Aγ –196 C→T, Aγ –117 G→A, Gγ –175 T→C and 
Gγ –158 C→T (or Gγ Xmn I, as presented in Table X). These mutations were already 
known to be present in Sardinia. 
All 
Aγ –196 C→T samples (5/17) showed a β–trait (β0(39)/β), normal levels of 
HbA2 (2.5 ± 0.1%) and HbF levels near to 20% (21.5 ± 2.2%). Hematological 
parameters in this group were normal (GM, CMA, MGB) or slightly varied (BL, CI). 
CI, GM and CMA showed the exclusive production of 
Aγ globin, while MGB and 
BL presented also 
Gγ globin. MGB was confirmed to be heterozygous for Gγ Xmn I 
polymorphism, while BL showed two substitutions (–474 C→T and –309 A→G) on 
the 
Gγ promoter. Cloning of this promoter in pSK established that these two 
mutations were in cis. 
Aγ –117 G→A was found on 7/17 samples, with normal β–globin genes. All 
these samples carried the Type 3 β–gene framework, where the synonymous 
mutation C→T at codon 2 (His→His) is present. HbF levels in this group were the 
less variable among all ndHPFH found in this study, settling at 14.4 ± 1.6%.  
4/7 produced only the 
Aγ globin; the others showed persistence of both γ globin, with 
peaks of ∼40% of Gγ globin (PG). Among the latest group, MS and PG showed a 
normal 
Gγ promoter, while DGI was heterozygous for Gγ Xmn I polymorphism. 
Only two samples were heterozygous for 
Gγ –175 T→C (CA, FVR), showing 
different levels of HbF (19.4% and 28.3%, respectively). Only these samples 
presented exclusive synthesis of 
Gγ globin. No β–thalassemic alleles were found in 
this group. 
Only 3 samples were solely heterozygous for 
Gγ –158 C→T (Gγ Xmn I): in fact 
no other ndHPFH mutation was found on either 
Gγ or Aγ promoter. This group is the 
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most heterogeneous with regard to the production of HbF in terms of quantity and 
quality. Also a different β–thalassemic allele was found on each Gγ –158 sample 
(Table X). 
CI, CR, CV, PG and OM samples were heterozygous for AGCA deletion  
(–225/–222) in the Aγ promoter: this deletion is known to be always present on the 
promoter of the gene encoding the 
AγT globin (Manca and Masala, 2008). 
All the 
Gγ promoters showed a homozygous GA→AG inversion at –535/–534, 
while all the 
Aγ promoters revealed a homozygous C→G transversion at –369. These 
differences could be due to rare SNPs in the reference sequence. 
MLPA for β–globin cluster was performed on samples which were thought to 
carry a dHPFH: only one sample 
(PF) showed the presence of a 
deletion (Sicilian δβ–thalassemia) 
(Fig. 28). GAP–PCR and subsequent 
sequencing analysis confirmed the 
same break–point of this deletion as 





Due to a recurrence of the β0(39) allele in Aγ –196 C→T samples and the 
synonymous C→T mutation at codon 2 on β gene in Aγ –117 G→A samples, Orkin 
haplotypes were analyzed to assess if an association between ndHPFH mutation and 
β–globin cluster was present. The Aγ –196 group showed haplotype I while  
Aγ –117 haplotype VII; both showed also a recombinant haplotype (Table XI). 
Furthermore, Orkin haplotypes were studied in BGi sample, heterozygous for 
β+(–87)/β: sequence analysis showed the presence of haplotype I and VIII  
(Table XI); in addition some other polymorphisms described by De Angioletti et al., 
2004 were identified. BGi revealed (AT)9N12(AT)10 motif in the β–LCR HS2 region, 
Figure 28 
Bar chart for PF sample analyzed with SALSA 




 .............................................................................................................................................. RESULTS 
Sandro Trova 
Analysis of genetic determinants associated with Persistent Synthesis of Fetal Hemoglobin 
PhD Thesis in Biomolecular and Biotechnological Sciences (Biochemistry and Molecular Biology) 
 Università degli Studi di Sassari 
82 
TAG at −1450, −1280, −1225 Gγ–globin gene (pre Gγ framework), T at −158  
Gγ–globin gene, (TG)11(CG)3 motif in the 
Gγ–IVS2, (TG)13 motif in the 
Aγ–IVS2, 
(AT)9T5 motif in β promoter. 
 
Reporter assays 
Luciferase assay performed on γ globin ndHPFH promoters compared to wild 
type promoters gave the following results: 
Aγ –196 C→T increased luminescence of 
∼1.4 fold, Aγ –117 G→A of ∼1.3 fold, Gγ –175 T→C of ∼3.5 fold (Fig. 29 A, B and 
C respectively). 
















It was also determined whether or not the two mutations found in BL (–474 
C→T and –309 A→G) were able to alter the expression of Gγ globin. Experiments 
showed a decrease of luminescence of 10% circa compared to the wild type promoter 
(Fig. 30 A). 
Moreover, since BL also carried 
Aγ –196 ndHPFH allele, the Aγ wild type and 
Aγ –196 promoter were cotransfected (Aγ pSK: Gγ pGL2 1:1): the decrease of 
expression of 
Gγ was not reverted and appeared higher in the presence of the mutated 
Aγ allele (a 10% decrease of luminescence compared to the one from the 
cotransfection with wild type 
Aγ) (Fig. 30 B). 
Figure 29 
Luciferase assay results for ndHPFH 
promoters. 
A) 
Aγ –196 C→T 
B) 
Aγ –117 G→A 
C) 
Gγ –175 T→C 
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 A. B. 
 
Figure 30 
Luciferase assay results for BL mutated promoter. 
A) 
Gγ muted promoter (–474 C→T and –309 A→G) 
B) Cotransfection of 
Gγ muted promoter (–474 C→T and –309 A→G) + Aγ WT or Aγ –196 C→T 
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The β–thalassemias occur with a very high clinical variability, even in presence 
of the same genotype, suggesting that different genetic determinants can modulate 
the clinical course of the disease. Unfortunately, γ–globin genes are switched off 
during the development even in presence of one or two defective β–genes. Either the 
absence or the significant reduction of β–globin leads to the accumulation of  
α–globin within the cell. Free α–globins precipitate and damage the membranes of 
RBC precursors causing ineffective erythropoiesis. 
In general, any factor that reduces the imbalance between α/non–α globin can 
improve the clinical phenotype (β+–alleles, α–thalassemia, higher expression of 
AHSP, persistence of HbF).  
Among them, Hereditary Persistence of Fetal Hemoglobin (HPFH) syndrome, 
which leads to a non–silenced γ–gene in adulthood, appears to be the most effective: 
patients with a TM genotype (β0(39)/β0(39)), although they are expected to suffer of 
a severe transfusion dependent anemia, show a TI phenotype, mostly because of the 
persistence of HbF. In fact, the γ–globin genes activity causes an increase in HbF 
that is able to reduce the α/non–α globin imbalance and compensate for the 
biosynthetic lack of HbA, typical of these pathologies. 
Unfortunately, this phenomenon occurs in a limited number of people, so it is 
very rare that the persistence of HbF is coinherited in presence of β–thalassemia 
(Para. 3.2). 
 
Recently, given such evidences, research interest has been directed to the 
design of new strategies aimed at reactivation of γ–globin genes. The development of 
alternative therapies based on the modulation of the expression of target genes and 
the control of Hb fetus→adult switch, however, requires a deep knowledge and 
complete understanding of the complex molecular mechanisms that regulate globin 
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This research intends to increase knowledge about the regulation of γ–globin 
genes, with particular attention to the switch fetus→adult. It may also give support to 
the current pre– and post–natal diagnosis and therapeutic approach of β–thalassemia, 
in order to prevent unnecessary and harmful transfusion regimes. 
 
First level analysis 
Samples were first screened for hematological data and hemoglobin profiles 
(Table VIII). Blood samples from donors were analyzed by means of hematocrit and 
CE–HPLC, so it was possible to evaluate the hematological parameters and profile of 
Hb tetramers. 
Through CE–HPLC samples with HbF levels higher than 5% were selected: in 
this way hHPFH samples were excluded from the analysis (Chap. 4). Moreover, a 
first screening of extra–peaks (in addition to HbF, HbA and HbA2) was carried out. 
Given that CE–HPLC is not able to discriminate some variants like the  
HbJ–Sardegna (αJ–Sardegna, cod. 50 His→Asp), which coelutes with HbF, the Hb 
tetramers were also separated by IEF. The presence of HbF was therefore confirmed 
and samples that showed HbJ or other extra–bands were excluded. 
For this purpose, also globin monomers were separated by AUT–PAGE and 
RP–HPLC. 
Moreover RP–HPLC gave a relative quantification of individual globins and 
defined the quality of HbF (
Gγ/Aγ ratio) with greater sensitivity than AUT–PAGE. 
No sample showed, by means of CE–HPLC or IEF, the presence of HbH (β4) 
homotetramer. It appears as a narrow peak which elutes immediately in CE–HPLC 
or as a very anodic band in IEF. The presence of HbH is associated with the deletion 
or malfunction of at least two of the four α genes: β–globins, without enough α 
counterparty, homotetramerize and form a Hb which is not useful to the transport of 
O2 (Para. 3.1.1). 
The lack of HbH in the analyzed samples made it possible to establish, in good 
confidence, that at least 3/4 α genes were functioning. Since a single not functional α 
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gene is not able, alone, to improve the thalassemic phenotype, it was decided not to 
analyze the α–cluster at the molecular level. 
HbA2 was found increased in 2 samples (BGi, OM), later explained by the 
presence of a β–trait (Table VIII). 
The HbF levels were very heterogeneous (Table VIII), ranging from a 
minimum of 8.6% (OM) to a maximum of 28.3% (FVR), with 2 recurring mean 
values (∼15% and ∼22% of HbF). This data emphasizes the extreme variability in 
the multifactorial and not yet fully explained persistence of HbF. 
 
Hematological data of the samples made it possible to distinguish normal 
samples from carriers of α– and β–thalassemia. 
The parameters were normal, except for a few patients (BGy, BGi, BL, CI, 
OM, PF). Two samples (BGi and OM) showed higher than normal levels of HbA2 
(>5% against a normal value of ≤ 3.2). Molecular results explained these 
hematological alterations except for BGy (See Below). 
 
Second level analysis 
After the initial screening by means of electrophoretic and chromatographic 
techniques, the molecular investigation was carried out on the 17 samples that 
showed no structural variants. 
The entire β–gene was sequenced in all samples: 6 were β0(39)/β, 1 was  
β+(–87)/β (Table IX). In addition, PF showed a large deletion which removes the  
β–globin gene (Sicilian δβ–thalassemia, See Below). 
In total 8/17 samples were carrier of a β–thalassemia allele: only 2 of them 
(OM and BGi) showed the HbA2 increase typical of β–trait, while for the other 
samples it was impossible to predict the mutated allele from the hematological 
parameters (Table VIII). The slight decrease or normal values of MCV and MCH, in 
addition to normal levels of HbA2 in samples BL, CMA, CI, GM and MGB was later 
explained by the presence of 
Aγ –196 C→T ndHPFH mutation linked to the β0(39) 
allele (See below). 
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PF instead, heterozygous for Sicilian δβ–thalassemia, lacks a functional δ gene 
and that explains normal levels of HbA2. 
Only BGy’s lower MCV and MCH were not explained by her β–globin genes, 
which turned out to be normal. Therefore, for this sample, an α–thalassemia trait is 
plausible, although the reductions in hematological parameters are so mild (in 
addition to the absence of HbH) that at best a single dysfunctional α–gene would be 
suspected. 
 
Promoters of fetal genes were sequenced on the basis of either 
Gγ or Aγ or both 
globin produced by each sample. 
Four ndHPFH were found: 
Aγ –196 C→T, Aγ –117 G→A, Gγ –175 T→C and 
Gγ –158 C→T (or Gγ Xmn I, as presented in Table X). These mutations were already 
known to be present in Sardinia. 
 
Gγ –175 T→C 
2/17 samples (CA and FVR) showed persistence of only 
Gγ and turned out to 
be heterozygous for 
Gγ –175 T→C mutation (Para. 4.2.3). This mutation is one of the 
strongest ndHPFH, capable of pushing HbF up to 20.3 ± 2.8%. 
Gγ –175 T→C is 
besides linked to normal hematological values and a HbF, mostly α2
Gγ2  
(94.0 ± 5.2%) (Steinberg et al., 2009) (Table VI). 
CA showed HbF=19.4%, 100% α2
Gγ2, in accordance with literature, while 
FVR showed a much higher level of HbF (28.3%). The sequence analysis performed 
on the β–gene highlighted different β–gene framework (Type 3) in CA respect to 
FVR. Type 3 framework (TGTTC) (Orkin et al., 1982) possesses the synonymous 
mutation at codon 2: it falls on one of the three E–box (Enhancer box) present within 
the β–gene (Leach et al., 2003). Leach and colleagues demonstrate that mutations at 
the level of E–box can reduce the binding affinity for activators of transcription 
(Para. 2.1); these factors could be therefore free to bind γ–globin promoters. 
This hypothesis is in disagreement with data obtained for samples CA and 
FVR; FVR in fact expresses higher levels of HbF, although CV showed the mutation 
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on the E–box. The difference may be due to other cis– and trans–acting factors, not 
least the other IVS2 SNPs which characterize the Type 3 framework that, even if 
described as polymorphic sites, have never been associated with the modulation of 
the expression of fetal genes. Up to now, in fact, two of these polymorphisms (+81 
and +666) have been studied only in association with β–thalassemia and βS alleles 
(Bilgen et al., 2011). 
Further studies are necessary to verify the possible involvement of these SNPs 
on gene expression in 
Gγ –175 T→C ndHPFH subjects. 
 
Gγ –158 C→T 
The 
Gγ –158 C→T or Gγ Xmn I polymorphism (Para. 4.2.4) was found in 5 
samples, two of which (DGI and MGB) were also carriers of mutations 
Aγ ndHPFH. 
Given the high incidence of 
Gγ –158 (33–35%) in normal population, it is not 
surprising to observe it in association with 
Aγ –117 (DGI) or Aγ –196 (MGB) 
ndHPFH mutations. These two samples will be discussed below. 
Regarding BGi, OM and PF, characterized by the sole presence of the Xmn I 
polymorphism, they were very different in terms of the amount of HbF and its 
quality (Table X). The cause of this differences in phenotype is unknown as no 
transcription factors seem to bind there, but it may be related to the different 
chromosomal backgrounds and mutations on other genes involved in Hb switch, 
which are in linkage disequilibrium with this SNP (Steinberg et al., 2009). Moreover, 
by hematological data in all three patients and higher HbA2 in BGi and OM, the 
presence of a β–trait was assumed. 
 
BGi, within this group, showed the greatest proportion of HbF. The analysis of 
the β–genes on this sample verified the presence of the β+(–87) mutation in 
heterozygosis, on a Type 2/2 β–framework. 
Given that β+(–87) is known to be present on two different haplotypes  
of β–cluster, one overexpressing HbF (Gγ/Total γ = 69.4 ± 2.6%) (Fig. 17)  
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(De Angioletti et al., 2004), Orkin haplotypes, microsatellite and polymorphisms 
described in De Angioletti’s work were characterized.  
All results are comparable to those found in the overexpressing HbF haplotype; 
thus, the proportion of HbF in BGi seems to be explainable with the haplotype 
described by De Angioletti. 
Furthermore, although haplotype VIII had already been described in 
association with Type 2 β framework (Orkin et al., 1982), this framework was found 
in Haplotype I in this study; this observation was confirmed also in BL. 
 
OM showed levels of HbF equal to 8.6%, with a ratio of about 80:20 in favor 
of 
Gγ. The sequence of the β–gene showed β0(39) allele in homozygosis. It could be 
surprising to see the 
Aγ–globin rise up to a 20% in the presence of a normal Aγ 
promoter (Table X). However Xmn I polymorphism had already been associated with 
concomitant activation of 
Gγ and Aγ globin gene transcription on a β0–thalassemia 
chromosome. Nevertheless, whether or not the −158 Xmn I polymorphism was 
responsible alone for the activation of both γ genes, was not elucidated so it is 
possible a coinheritance of other genetic modifiers, such as QTLs for HbF that are 
not linked to the β globin complex (Haj Khelil et al., 2011). 
 
Although PF showed 
Gγ –158 C→T and HbF levels similar to OM, he showed 
inverted 
Gγ:Aγ ratios (20:80 for PF vs 80:20 for OM). Moreover, even in this case, no 
Aγ–ndHPFH mutation which could explain the increase of Aγ–globin was found. 
However, even though hematological parameters were profoundly altered 
(suggesting a β–trait), the HbA2 turned out to be normal (Table X).  
A deletion was therefore suspected, causing the increase of HbF and involving 
also the δ–gene (dHPFH or δβ–thalassemia). The entire β–cluster was analyzed by 
means of MLPA, revealing a heterozygous deletion from the third exon of δ gene up 
to a non–well–defined region (for lack of probes), approximately 9 kb downstream 
β–gene, in which the 3’ breakpoint could be found. 
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Basing our study on work published by Craig et al., 1994, the most probable 
deletion, compatible with the information obtained by MLPA, was the Sicilian  
δβ–thalassemia which was subsequently confirmed by GAP–PCR and sequencing. 
This deletion involves a fragment that starts 188 bases before the beginning of the 
third exon of the δ–gene delta and ends at 5,710 bp downstream of the termination 
codon of the β–gene, removing 13,378 bp (Table IV). Heterozygotes for Sicilian  
δβ–thalassemia show mild anemia, typical thalassemic RBC morphology, 
hypochromia, basophilic stippling, increased HbF (4.0–18.6%), low/normal HbA2 
(2.3%), and 25–56% Gγ levels (http://globin.bx.psu.edu). Hematological results of PF 
are in agreement with the ones already described in literature.  
 
Aγ –117 G→A  
The 
Aγ –117 G→A (Para. 4.2.1) is known to be linked to normal hematological 
data except for the production of HbF (12.1 ± 2.8%), mostly
 Aγ (93.4 ± 4.7%) (Table 
VI) (Steinberg et al., 2009). This mutation was found in 7 samples, all expressing 
similar HbF levels (14.4 ± 1.6%): 4 of them (BG, BGy, CR, CV) expressed only the 
Aγ globin, as expected from literature. MS, PG and DGI, on the contrary, also 
expressed the 
Gγ–globin. DGI was found heterozygous for Gγ Xmn I, and this could 
explain the persistence of 
Gγ–globin. 
However MS and PG revealed a normal 
Gγ–gene promoter and, therefore, it 
still remains unclear the cause of the synthesis of 
Gγ globin in these two patients. 
Complete β–gene sequence showed normal β–alleles in all these samples and a 
recurrent Type 3 β–framework (TGTTC). Aγ –117 samples were the only ones in this 
study in which Type 3 framework can be found, suggesting that the mutation 
originated only once on the same β–cluster. CV and DGI were therefore analyzed for 
Orkin haplotype and revealed the presence of haplotype VII, as expected from 
literature (http://globin.bx.psu.edu and Pistidda et al., 1995). This is the only 
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Aγ –196 C→T 
The 
Aγ –196 C→T (Para. 4.2.2) is associated with normal hematological data 
and 13.7 ± 2.0% of HbF, mostly 
Aγ type (95.0 ± 0.2%) (Table VI) (Steinberg et al., 
2009). In this study this mutation was observed in 5 samples: HbF levels were higher 
than the ones just described (21.5 ± 2.2%). All samples were heterozygous for the 
β0(39) allele, and this difference from the reference data could be the cause of higher 
level of HbF in the samples analyzed in this study. β–gene frameworks and 
haplotypes (Table X and XI) were very variable, meaning that this mutation either 
originated on different chromosomes or is very old and recombined on different 
haplotypes. 
It is important to emphasize that in all of these samples no/slight changes in 
hematological values and HbA2 levels were found, despite the β–trait. 
The lack of increase of HbA2 in presence of heterozygous β
0
(39) allele has 
already been described and this association is named Sardinian δβ–thalassemia 
because of the presence of a β–thalassemia allele and the reduced amount of δ globin 
(HbA2). It is supposed that the reason why δ–globin gene is under–expressed, 
although the δ gene is entirely normal, is probably imputable to the suppressive 
effect of the cis 
Aγ –196 ndHPFH mutation, which may compete for the transcription 
factors and β–LCR (Loudianos et al., 1992). Moreover, among ndHPFH found in 
this study, 
Aγ –196 is the only one that could compensate MCV and MCH up to 
normal values, in presence of β–thalassemia allele. 
CI, GM, and CMA showed only 
Aγ globin, while MGB and BL produced also 
Gγ. MGB was carrier of Gγ Xmn I and this could cause the persistence of Gγ, while 
BL was –/– for this polymorphism. However BL presented two heterozygous 
substitutions in cis on the 
Gγ promoter: the –474 C→T mutation, never described, 
and the –309 A→G, a known polymorphism, never associated with the persistence of 
HbF, but only used to define peculiar haplotypes associated with βS (Barbosa et al., 
2010) or 5’ sub–haplotype in De Angioletti’s work (De Angioletti et al., 2004). 
Given that BL showed persistence of 
Gγ, it was supposed that the two substitutions 
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could act in synergy or individually, increasing the synthesis of this globin. The 
reporter assay results, discussed below, disproved this hypothesis. 
 
The nucleotide sequencing of the 
Aγ promoter revealed a deletion of 4 bp in 
heterozygosis, from –225 to –222 (AGCA), in samples CI, CR, CV, PG and OM. It 
is known that this deletion characterizes the 
AγT locus, whose globin tetramerizes in 
HbF–Sardegna (α2
AγT2), the most common HbF variant in the world [
Aγ75 (E19) 
Ile→Thr] (Manca and Masala, 2008). The incidence of this variant is so high in the 
Sardinian population (33%), that it could be considered a polymorphism. 
Manca and Masala, 2008 believe that the presence of the –225/–222 deletion 
on the promoter reduces the binding efficiency of some transcription factors, 
resulting in a slightly reduced synthesis of 
AγT globin compared to the normal AγI.  
Although the samples mentioned above were heterozygous for the 
AγT allele, 
none of them showed persistence of the corresponding globin, perfectly recognizable 
from 
AγI by the screening techniques used in this study. There is no data on ndHPFH 
mutations which leads to the expression of 
AγT globin. This could mean that  
1) ndHPFH mutations occurred only on the 
AγI locus; 2) if a ndHPFH mutation 
affects a 




To assess whether a single ndHPFH mutation in the 
Gγ and Aγ genes was able 
to modify the strength of the associated promoter, expression assays were performed 
by means of luciferase as a reporter gene. 
The wild type and mutated promoters of 
Gγ and Aγ were inserted upstream of 
the luciferase gene (in the plasmid pGL2–Basic) and their luminescence was then 
evaluated (Chap. 9). 
To validate this system, 
Gγ –175 promoter, already known to increase the 
luminescence of 4 fold circa (Li et al., 2001), was constructed and transfected in 
K562 cells. In our experiments the luminescence was increased by 3.6 fold circa, 
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confirming that the system gives reproducible results. The differences were 
statistically significant (p=0.01). 
Aγ –117 RNA synthesis had already been evaluated through transient 
expression assay and produced about 1.4 fold as much RNA as the wild type 
Aγ gene 
when standardized against RNA transcribed from the 
Gγ genes in cis (Rixon and 
Gelinas, 1988). In this study, the strength of 
Aγ –117 was evaluated by means of 
luciferase assay, showing an increase of 1.34 fold (p<0.01), perfectly consistent with 
previous findings. 
The 
Aγ –196 promoter expression had been already analyzed and did not show 
any increase in gene expression in vitro (Ronchi et al., 1989). In this study, when 
transfected in K562 for the luciferase assay, the 
Aγ –196 showed an increase of 1.42 
fold, compared to the wild type 
Aγ promoter (p <0.01). Therefore, it is plausible that 
the luciferase assay is more sensitive than the expression assay chosen by Ronchi et 
al., 1989. 
Two mutations had been already described in the proximity of 
Aγ –196: the 
first, 
Aγ –198, is able to increase the expression of the associated gene of 4–5 fold (Li 
et al., 2001), while the second, 
Aγ –195, shows a very slight increase of Aγ if HS2 
enhancer is not present; consequently, HS2 is necessary for an effective action of the  
Aγ –195 promoter (Takahashi et al., 2003). Although the Aγ –196 mutation does not 
show an increase as high as 
Aγ –198, it still proves to be able to determine a visible 
increase of luminescence even in the absence of HS2. Hence, 
Aγ –196 turns out to be 
a stronger ndHPFH mutation compared to the 
Aγ –195. 
 
It was also determined whether or not the two mutations found in BL 
Gγ 
promoter (–474 C→T and –309 A→G) were able to alter the expression of Gγ globin. 
Luciferase assay showed a decrease of luminescence of 10% circa compared to the 
wild type promoter (p<0.05). 
This result invalidated the hypothesis that the two mutations could be 
responsible for the 
Gγ persistence in BL sample; however it should not be surprising: 
in fact –474 C→T mutation falls on the “silencing” region of the γ gene (Para. 2.1) 
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and could create a binding site for repressors, reducing the synthesis of the gene 
associated with the mutated promoter. Hence, it is possible that the mechanisms that 
increases 
Gγ resides in other cis– and trans–agent factors. 
Since BL also carried 
Aγ –196 ndHPFH allele, to exclude trans–activation of 
Gγ gene, the Aγ wild type and Aγ –196 promoter were cotransfected. The decrease of 
expression of 
Gγ was not reverted and appeared higher in the presence of the mutated 
Aγ allele (a 10% decrease), meaning that Aγ –196 is not able to trans–activate Gγ gene 
in presence of –474T and –309G mutations. The decrease in the presence of Aγ –196 
is easily explainable: the 
Aγ –196 promoter is stronger than the Aγ wild type and this 
means that it has a better ability to bind transcription activators. It is clear that in the 
presence of the 
Aγ –196, more transcription factors are “captured” by the mutated Aγ 
promoter, thereby reducing the efficiency of transcription of the 
Gγ promoter. 
Unfortunately, these results did not explain the reason for the persistence of 
Gγ 
globin in the BL sample. 
 
The enhancement produced in these luciferase assays was demonstrated to be 
several times less than that seen in vivo. However, the results are similar to those 
described with other mutations and refer to a promoter which is decontextualized 
from the β–cluster: it is not possible to predict a different behavior in terms of in vivo 
expression. For example, the presence of β–LCR (or HS2 alone) could change the 
final result of the assay, by increasing the difference in γ promoter activation as it 
was proved with the 
Aγ –195 mutation (Takahashi et al., 2003). 
 
The data presented in this thesis confirm the complexity of the globin switch 
and the heterogeneity of the molecular mechanisms underlying the persistence of 
HbF, emphasizing the importance of the molecular context of a mutation. 
The ability to associate a given mutation or a given combination of 
polymorphisms to higher HbF levels in adulthood could clarify the likelihood of a  
β–thalassemic fetus to develop a mild disease during extra–uterine life, and 
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Table I 
Role of β–LCR 5’ Hypersensitive Sites (HSs)  
(Harju et al., 2002) 
 
5’ HS4 
Transcription activation activity 
Position–independent expression 
Copy number–dependent expression 
5’ HS3 
Transcription activation activity 
Position–independent expression when linked to β–globin gene 
Copy number–dependent expression when linked to β–globin gene 
Position–dependent expression when linked to Aγ–globin gene 




Copy number–dependent expression 
Binding sites for GATA1, NF–E2, Sp1, Ap–1, USF; all necessary for 
enhancer function 
Deletion of single GATA1–NF–E2, Sp1, or USF site does not impair 
position–independent expression 
373 bp HS core confers position–independent expression 
5’ HS1 
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Table II 
Classification of Hemoglobin Disorders 
(Forget and Bunn, 2013) 
 
A. QUANTITATIVE DISORDERS OF  
GLOBIN CHAIN SYNTHESIS/ACCUMULATION 
















“Dominant” β–thalassemia (structural variants with β–thalassemia phenotype) 





Deletions of α–globin genes: 
One gene: α+–thalassemia 
Two genes in cis: α0–thalassemia 
Two genes in trans: homozygous α+–thalassemia (phenotype of α0–thalassemia) 
Three genes: HbH disease 
Four genes: Hydrops fetalis with Hb Bart’s 
Nondeletion mutants: 
Hb Constant Spring 
Other 
De novo and acquired α–thalassemia 
α–Thalassemia with mental retardation syndrome (ATR): 
Due to large deletions on chromosome 16 involving the α–globin genes 
Due to mutations of the ATRX transcription factor gene on chromosome X 
α–Thalassemia associated with myelodysplastic syndromes (ATMDS): 
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B. QUALITATIVE DISORDERS OF GLOBIN STRUCTURE:  
STRUCTURAL VARIANTS OF HEMOGLOBIN 
 
Sickle cell disorders 
SA, sickle cell trait 
SS, sickle cell anemia/disease 
SC, HbSC disease 
S/β thal, sickle β–thalassemia disease 
S with other Hb variants: D, O–Arab, other 
SF, Hb S/HPFH 
 
Hemoglobins with decreased stability (unstable hemoglobin variants) 
Mutants causing congenital Heinz body hemolytic anemia 
Acquired instability—oxidant hemolysis: Drug–induced, G6PD deficiency 
 
Hemoglobins with altered oxygen affinity 
High/increased oxygen affinity states: 
Fetal red cells 
Decreased RBC 2,3–BPG 
Carboxyhemoglobinemia, HbCO 
Structural variants 
Low/decreased oxygen affinity states: 





Cytochrome b5 reductase deficiency 
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Table III 
Hematological reference values of Red Blood Cells 
 
Parameter Patient Lower limit Upper limit Unit 
Hemoglobin (Hb)
[1]
 M 13.2 16.2 g/dl 
 
F 12 15.2 g/dl 
Glycosylated hemoglobin (HbA1c)
[2]
 < 50 y 3.6 5 % of Hb 
 
> 50 y 3.9 5.3 % of Hb 
Mean cell volume (MCV)
[1]
 M 82 102 fl 
 
F 78 101 fl 
Red blood cell distribution width (RDW)
[1]
  11.5 14.5 % 
Mean cell hemoglobin (MCH)
[3]
  25 35 pg/cell 




 31 35 g/dl 
Erythrocytes/Red blood cells (RBC)
[1]
 M 4.3 6.2 mln/μl 
 
F 3.8 5.5 mln/ μl 
Reticulocytes
[1]
 Adult 0.5 1.5 % of RBC 
 
Newborn 1.1 4.5 % of RBC 
 




 Normal Reference Range Table from The University of Texas Southwestern Medical Center at 
Dallas. Used in Interactive Case Study Companion to Pathologic basis of disease. 
[2]
 Reference range list from Uppsala University Hospital ("Laborationslista"). Artnr 40284 Sj74a. 
Issued on April 22, 2008. 
[3]
 Deepak A. Rao; Le, Tao; Bhushan, Vikas (2007). First Aid for the USMLE Step 1 2008 (First Aid 
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Table IV 
Some of the principal deletions and their breakpoints in  
δβ–thalassemia and dHPFH 
(Steinberg et al., 2009) 
 




 HPFH–1 (Black) ~4 kb 5’ to the δ gene 
~95 kb from the 3’ end of the 
β gene 
84.918 
 HPFH–2 (Ghanaian) IVS2 of the pseudo β gene 
~90 kb downstream from the 
3’ end of the pseudo β gene 
84.281 
 HPFH–3 (Indian) 5’ end of the pseudo β gene 30 kb downstream of the β gene 49.733 
 HPFH–4 (Italian) 5 kb from the 5’ to the δ gene ~30 kb 3’ to the β gene ∼40 




~3.5 kb 5’ to the δ gene 
~8 kb 3’ to the breakpoint f 
ound in HPFH–3 
30 
     
GγAγ(δβ)0 thalassemia 
 Sicilian 
δ–IVS2, 188 bp from 
the beginning of the third exon 
5,710 bp 3’ to the termination 





1.7 kb 5’ to the δ gene 
within the 5’ end of the 
β gene 
∼9.5 
 Black ~2.4 kb 5’ to the δ gene to 200 bp at the 
3’ end of the β gene, before 
Alu Repeats 
11.803 
 Indian 1 kb 3’ of the 
Aγ–globin gene >10 kb 3’ of the β gene 32.624 
 Spanish 
Midpoint between the pseudo β and 
δ genes into the inverted Alu I repeat 
~100 kb 3’ to the β gene ∼93 
 Japanese 
2134 and 2137 bp 3’ to the poly A 
site of the 
Aγ gene 
β gene (165148) 113.63 
 Turkish 
1.5 kb 5’ to the enhancer–like 
sequence of 
Aγ 
L1 repeat sequence 3’ to the 
β gene 
∼30 





3’ to the Gγ gene 
More than 45 kb from the 
3’ end of the β gene 
79.278 
 Black IVS–II in the 
Aγ gene to 200 bp 




Aγ–IVS–II and extends 
~75 kb downstream from 
the β gene 
78.847 
 Italian exon 2 of the 
Aγ gene ~30 kb 3’ to the β gene ∼52 
 Belgian 3’ end of the 
Aγ 




1.5 to 1.9 kb from the 3’ end of the Gγ 
gene 
27 kb 3’ to the β gene ∼52 
 Turkish 
1,075 bp 3’ to the termination codon 
of the 
Gγ gene 
9,657 bp 3’ to the termination 
codon of the β gene 
36.211 
 Malay 2 0.2 to 0.4 kb 5’ to the 
Aγ gene 
beyond sequences 17 to 18 kb 
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Table V 
Hematological data (mean ± SD) on δβ–thalassemia and dHPFH  
heterozygotes and homozygotes 





































 HPFH 13–2 ± 0.6 82.6 ± 4.1 26.3 ± 1.4 2.2 ± 0.4 24.1 ± 2.7 16–71 84–29 P 
        



















 HPFH 16.6 ± 1.1 71.9 ± 3.4 24.5 ± 1.3 0 100 54–65 46–35 P 
 
 
H: Heterocellular distribution. 
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Table VI 
Summary of hematological data (mean ± SD) on ndHPFH 
heterozygotes defined by molecular analysis 

















Xmn I +/– 
Black −202 C→G 13.3 ± 1.3 82.0 ± 6.5 27.7 ± 2.0 1.7 ± 0.4 15.6 ± 1.2 99.0 ± 0.5 – 




−175 T→C 12.7 ± 1.1 85.2 ± 3.1 28.4 ± 1.8 1.3 ± 0.2 20.3 ± 2.8 94.0 ± 5.2 – 
Japanese −114 C→T      12.5 ± 2.1 + 
Australian −114 C→G 14.2 92  2.3 8.6 90 – 
Algerian −114 C→A    2.6 ± 0.3 1.5 ± 0.8 91.9 ± 3.5 – 

















Xmn I +/– 
Black −202 C→T 12.9 ± 0.9 84.4 ± 5.9 30.0 ± 2.3 2.7 ± 1.0 2.5 ± 0.9 92.8 ± 2.8 – 
British −198 T→C 14.2 ± 1.2 83.1 ± 3.3 29.0 ± 1.0 2.5 ± 0.4 6.9 ± 2.2 92.2 ± 1.8 – 
Italian/ 
Chinese 
−196 C→T normal normal 30.0 ± 0.9 1.8 ± 0.6 13.7 ± 2.0 95.0 ± 0.2 – 
Brazilian −195 C→G normal normal normal 2.1 5.4 ± 1.4 89.0 ± 2.5  
Black −175 T→C normal normal normal 1.5 ± 0.2 37.4 ± 1.0 78.0 ± 5.5 + 
Cretan† −158 C→T 13.9 ± 0.7 84.5 ± 6.0 27.3 ± 1.0 2.8 ± 0.2 3.7 ± 1.2 43.3 ± 8.6 + 
Greek/ 
Black 
−117 G→A 14.2 ± 1.1 85.9 ± 4.5 28.4 ± 2.4 2.0 ± 0.3 12.1 ± 2.8 93.4 ± 4.7 – 
Black †† −114/−102del 11.4 ± 2.9 75.5 ± 2.1 26.8 ± 0.3 2.1 ± 0.0 31.0 ± 1.2 85.7 ± 5.7 – 
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Table VII 
Primers used for PCR, Sequencing and Cloning 
 
PRIMER  SEQUENCE (5’→3’) Position Locus 
 
β–gene locus 
P1 (Fw): GCCAAGGACAGGTACGGCTGTCATC 61997–62021 β 
P2 (Rev): CCCTTCCTATGACATGAACTTAACCAT 62676–62702 β 
β7 (Fw): TCCTGATGCTGTTATGGGCAA 62469–62489 β 
β8 (Rev): AAAAGCAGAATGGTAGCTGGA 63371–63391 β 
β9 (Fw): AAAAACTTTACACAGTCTGCC 62935–62955 β 
     
β10 (Rev): ATTAGCTGTTTGCAGCCTCA 63881–63900 β 
γ–gene locus 
R159 (Fw): TGAAACTGTGGTCTTTATGAAAATTG 38792–38817 
Aγ 
R160 (Fw): GCACTGAAACTGTTGCTTTATAGGAT 33855–33880 
Gγ 










Gγ2 (Rev): AAGTGTGGAGTGTGCACATGA 36183–36203 
Gγ 





Aγ10 (Rev): ACTCAGCTGCAATCAATCCA 41309–41328 
Aγ 
SNPs and Microsatellites 
HS2_F (Fw): CCATAGTCCAAGCATGAGCA 8544–8563 β–LCR 
HS2_R (Rev): ATAGAGGCCACCTGCAAGATA 8986–9006 β–LCR 
5’ε _F[1] (Fw): TCTCTGTTTGATGACAAATTC 18652–18672 5’ ε 
5’ε _R[1] (Rev): AGTCATTGGTCAAGGCTGACC 19391–19411 5’ ε 
pre_Gγ_F (Fw): GAGTAACTGGAAGATACTGATAA 32965–32987 5’ 
Gγ 
pre_Gγ_R (Rev): AACTCGATCCATGACCTTGG 33264–33283 5’ 
Gγ 
pseudo_β_F (Fw): GAACAGAAGTTGAGATAGAGA 46426–46446 Ψβ 
pseudo_β_R (Rev): ACTCAGTGGTCTTGTGGGCT 47107–47126 Ψβ 
3’pseudo β_F (Fw): TCTGCATTTGACTCTGTTAGC 49476–49496 3’ Ψβ 
3’pseudo β_R (Rev): GGACCCTAACTGATATAACTA 50069–50089 3’ Ψβ 
pro_β_F (Fw): TAAGAGGTCTCTAGTTTTTTATCTC 61413–61437 5’ β 
pro_β_R (Rev): CTACCATAATTCAGCTTTGGGAT 61745–61767 5’ β 
3’β_Bam_F (Fw): GCTACGGTAACCAAAACAGCA 71809–71829 3’ β 
3’β_Bam_R (Rev): GGGGTTGTTTGTTTTTTCTTG 72350–72370 3’ β 
Sicilian δβ–Thalassemia (dHPFH) 
F1
[2]
 (Fw): TTGGGTTTCTGATAGGCACTG 54954–54974 δ 
F2
[2]
 (Rev): GTGTCACCCATTAATGCCTTGTAC 56515–56538 3’ δ 
F3
[2]
 (Rev): TAGATCCCTTTGCCATTATG 69463–69482 3’ β 
 
[1]
 (Falchi et al., 2005) 
[2]
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PRIMER  SEQUENCE (5’→ 3’) Position Locus 
γ promoter [Cloning] 
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Table VIII 





















BA F nd 14.5 – 100 nd nd nd nd 
BL* F 2.6 23.5 22.9 77.1 4.59 11.8↓ 80.3↓ 25.7 
BGy F 2.1 11.9 – 100 4.92 12.1 75.1↓ 24.7↓ 
BGi* F 5.7↑ 21.4 63.6 36.4 6.14↑ 14.3 71.2↓ 23.3↓ 
CA M nd 19.4 100 – nd nd nd nd 
CMA* F 2.6 20.7 – 100 4.52 12.6 82.3 27.8 
CV M 1.8 16.5 traces 100 5.08 13.9 86.6 27.3 
CI* M 2.5 18.8 traces 100 6.37↑ 16.1 81.6↓ 25.3 
CR M 2.0 13.2 traces 100 5.29 15.6 87.6 29.5 
DGI F 1.7 13.5 25.2 74.8 4.69 11.8↓ 80.9 25.2 
FVR F 1.7 28.3 100 – nd nd nd nd 
GM* M 2.4 20.5 traces 100 nd nd nd nd 
MS F 2.2 15.9 20.4 79.6 5.04 13.6 82 27 
MGB* M 2.3 24.0 23.5 76.5 5.52 14.6 82.6 26.5 
OM* F 5.3↑ 8.6 78.9 21.6 5.42 11↓ 63.5↓↓ 20.3↓↓ 
PF* M 2.5 9.5 18.2 81.8 6.11 12.9↓ 62.9↓↓ 21.1↓↓ 
PG F 1.8 15.1 41.6 58.4 nd nd nd nd 
 
*  These samples were confirmed for a β–thalassemic trait by molecular analysis. 
Hematological reference values can be found in Table III. 
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Table IX 






















































































































































































































































+16, +74, +81, +666 nucleotides are numbered from the first nucleotide in IVS2. 
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Table X 
Hemoglobin profiles and molecular data of HPFH samples 
 













       
 
 
CA 19.4 100 
 
–/– T/C β/β 1/3 nd 
FVR 28.3 100 
 
–/– T/C β/β nd 1.7 
 
 












         
CI* 18.8 traces 100 –/– C/T β
0(39)/β 1/1 2.5 
GM 20.5 traces 100 nd C/T β
0(39)/β 1/Rec. 2.4 
CMA 20.7  100 nd C/T β
0(39)/β nd/nd 2.6 
MGB 24 23.5 76.5 –/+ C/T β
0(39)/β 1/1 2.3 
BL** 23.5 22.9 77.1 –/– C/T β
0(39)/β 2/2 2.6 
 
 












         
BA 14.5 traces 100 nd G/A nd nd nd 
BGy 11.9  100 nd G/A β/β 3/3 2.1 
CR* 13.2 traces 100 nd G/A β/β 3/3 2.0 
CV* 16.5 traces 100 nd G/A β/β 1/3 1.8 
MS 15.9 20.4 79.6 –/– G/A β/β 1/3 2.2 
PG* 15.1 41.6 58.4 –/– G/A β/β 1/3 1.8 
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BGi 21.4 63.6 36.4 –/+ None β
+
(–87)/β 2/2 5.7 
OM* 8.6 78.9 21.6 –/+ None β
0(39)/β 1/2 5.3 
PF*** 9.5 18.2 81.8 –/+ None –/β nd 2.5 
 
**  The samples are heterozygous for AGCA deletion (–225/–222) in the Aγ promoter. 
**  The sample BL presents two substitutions (–474 C→T and –309 A→G) on the Gγ promoter 
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Table XI 
Haplotypes of β–globin gene cluster  
in the analyzed samples  
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DNA extraction from Whole Blood 
 
SOLUTIONS FOR SALTING OUT 
 LYSIS BUFFER: 0.32 M Surcose, 10 mM Tris/Cl pH 7.5, 5 mM MgCl2, 1 % Triton X–100 
 PHYSIO BUFFER: 0.075 M NaCl, 0.025 M EDTA  
 BUFFER A: 10 mM Tris/Cl pH 8.0, 2 mM EDTA 
 Proteinase K: 10 mg/ml in 10 % SDS, 20 mM EDTA 
 NaCl 6 M 
 
LYSIS OF RBC 
 Add cold Lysis Buffer (4°C) to 2 ml of whole blood in EDTA, up to a volume of 10 ml 
 Mix gently by inversion 
 Incubate at 4°C for 15’–30’ 
 Centrifuge 20’ at 1500 g 
 Remove the supernatant 
 
WASH AND LYSIS OF WBC 
 Resuspend the pellet in Physio Buffer up to a volume of 10 ml 
 Centrifuge 10’ at 1500 g 
 Repeat the wash 2 more times with Physio Buffer 
 Discard the supernatant and lyse the pellet in 3 ml of Buffer A 
 Vortex to suspend and break up the pellet.  
DENATURATION AND REMOVAL OF PROTEINS 
 Add 100 ml of 10% SDS 
 Add 400–1000 μl of proteinase K in SDS  
 Incubate 37°C overnight 
• When the sample reaches the room temperature and add 1 ml of NaCl 6 M  
 Shake vigorously for 15’’ 
 Centrifuge 15’ at 1500 g 
 Transfer the supernatant into a clean tube 
PRECIPITATION AND RESUSPENSION OF DNA 
 Add 1 volume of isopropanol 100% 
 Centrifuge 15’ at 2200 g and discard the supernatant 
 Add 1 ml of ethanol 70% 
 Centrifuge 15’ at 2200 g and discard the supernatant 
 Wait for the evaporation of all EtOH 
 Add TE pH = 8 (500 μl – 1 ml) 
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Protocol 2 
Phenol:chloroform DNA purification 
 
 Add mQ water up to 200 μl to the solution containing DNA to be precipitated 
 Add 200 μl of phenol:chloroform:isoamylalcohol (25:24:1) (pH = 8) 
 Vortex for a few seconds to obtain a homogeneous emulsion 
 Centrifuge at top speed (20900 g) for 5’ 
 Recover the aqueous phase and put it into a new 1.5 ml tube  
 Add CH3COONa (3M, pH 5.5): 1/10 of the recovered aqueous solution 
 Add 2–2.5 volumes of 100% EtOH at room temperature 
 Add 1 μl of glycogen 10 mg/ml 
 Incubate at –80° C for 30’ or –20°C overnight 
 Centrifuge at top speed for 10’ 
 Remove the supernatant 
 Add 500 μl of 70% EtOH 
 Resuspend the pellet 
 Centrifuge at top speed for 5’ 
 Remove all the ethanol 
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Protocol 3 
Preparation of CaCl2 competent cells 
 




 Cloning forming Units per 1 μg of supercoiled plasmid DNA 
 
 Plate DH5α cells on LB agar without antibiotic and grow them overnight 
 Inoculate a colony of DH5α and incubate in 2 ml of LB, 37°C overnight, in agitation 
 Inoculate 500 μl of mini–inoculum in 100 ml of LB 
 Growth at 37°C in agitation 
 Stop the growth by putting the flask on ice (5–10’) when the Abs (OD) at 600 nm is 0.4 
 
 Pellet the bacteria by centrifugation at 1700 g for 10’, at 4° C 
 Remove the supernatant and resuspend with 20 ml ice cold 0.1 M CaCl2 
 Centrifuge again and remove the supernatant  
 Resuspend in 4 ml of ice cold CaCl2 + 10% sterile glycerol 
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Protocol 4 
Transformation of DH5α 
 
 Add 2–10 ng of supercoiled plasmid or ½ volume of the ligase reaction to a cold tube 
 Add 100 μl of competent cells to the tube 
 Incubate on ice for 30’ 
 Incubate 3’ at 37°C (thermal shock) 
 Incubate for 10’ at room temperature 
 
 In sterility, add 500 μl of LB broth (without antibiotic) 
 Incubate at 37°C for 50’ 
 Centrifuge for 5’ at 1900 g 
 Remove 500 μl of supernatant 
 Resuspend the pellet with the remaining volume of LB 
 Plate the cells on LB agar plate with specific antibiotic  
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Alkaline lysis in presence of SDS 
 
SOLUTIONS FOR MINI–PREPARATION 
Solution I: 50 mM glucose, EDTA10 mM Tris/Cl pH 8 25 mM 
Solution II: 200 mM NaOH, 1% SDS 
Solution III: 7.5 M NH4–acetate 
 
 Transfer 1 ml of mini–inoculation in a 2 ml tube 
 Centrifuge at 20900 g for 1’ and remove the supernatant 
 Resuspend the pellet in 200 μl of Solution I (Isotonic) 
 Add 200 μl of Solution II (alkaline lysis) 
 Mix gently by inversion 
 Incubate no more than 5’ at room temperature 
 Add 200 μl of cold Solution III 
 Incubate on ice 10’ 
 Centrifuge at 20900 g for 10’ 
 Recover the supernatant containing plasmid DNA and low molecular weight contaminants 
 Add 2 volumes of 100% EtOH and incubate 10’ at room temperature 
 Centrifuge at 20900 g for 15’ 
 Resuspend the pellet with 500 μl of 80% EtOH 
 Centrifuge at 20900 g for 5’ 
 Resuspend in 50 μl of TE containing RNase A (20 mg/ml) 
 Incubate at 37 ° C for 10’ 
 Use the extracted DNA for restriction digestion 
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LIST OF ABBREVIATIONS 
ACH:  Active Chromatin Hub 
AHSP:  α–hemoglobin stabilizing protein 
AUT–PAGE:  Acetic Acid, Urea, Triton X–100 PAGE 
CE–HPLC:  Cation Exchange HPLC 
GWAS: Genome–Wide Association Studies 
dHPFH:  Deletional HPFH 
Hb:  Hemoglobin 
HbA:  Adult Hemoglobin 
HBA1:  α1–globin gene 
HbA2:  Minor Adult Hemoglobin 
HBA2: α2–globin gene 
HBB:  β–globin gene 
HBD:  δ–globin gene 





hHPFH:  Heterocellular HPFH 
HPFH:  Hereditary Persistence of Fetal Hemoglobin 
HPLC:  High Performance Liquid Chromatography 
HS1–5:  DNase hypersensitive sites 
IEF:  Isoelectric focusing 
IVS:  Intervening sequence, Intron 
LCR:  Locus Control Region 
LD: Linkage disequilibrium 
MCH:  Mean Corpuscular Hemoglobin 
MCV:  Mean Corpuscular Volume 
ndHPFH:  non–deletional HPFH 
OR:  Olfactory Receptor 
ORF:  Open reading frame 
pHPFH:  Pancellular HPFH 
QTL:  Quantitative trait locus 
RBC:  Red blood Cells 
RP–HPLC:  Reversed Phase HPLC 
SCD:  Sickle cell disease 
UTR:  Untranslated region 
